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ABSTRACT 
 
In Eukaryotes, Argonaute (AGO) proteins have a well-
established role in the cytoplasm in post-transcriptional 
regulation of gene expression in association with different 
classes of small non-coding RNAs (sRNAs). 
In plants and yeast, it has been demonstrated that AGO 
proteins exert a role in the epigenetic regulation of chromatin 
modifications. Furthermore, AGO2 protein acts also in the 
nuclei of human cell lines and emerging literature reports that 
upon the transfection of sRNAs complementary to non-coding 
promoter transcripts, AGO2 is recruited on target promoters.  
Previous results in our laboratory demonstrated that AGO2 and 
SWI/SNF have a physical interaction, which is independent of 
RNA or DNA, in human cell lines. As SWI/SNF is the major 
chromatin-remodelling complex in human, these data suggest 
that AGO2 might participate in the regulation of chromatin 
plasticity. In eukaryotes, the proper organization of chromatin 
is essential for the control of gene expression and is achieved 
through the concerted activity of histone modifications, DNA 
methylation and nucleosome positioning. 
The focus of the present thesis has been the development of 
relevant bioinformatics pipelines for data processing, analysis 
and visualization, all aiming at dissection of the functional 
significance of the AGO2-SWI/SNF interaction. 
Interestingly, this bioinformatics pipeline allowed me to 
identify a novel class of nuclear AGO2-bound sRNAs arising 
from genomic regions 150 nt around the Transcription Start 
Sites (TSS) bound by SWI/SNF (swiRNAs). Furthermore, 
swiRNAs present a Dicer-dependent processing and show an 
involvement in nucleosome occupancy at nucleosome +1. 
These data represent the first description of a molecular 
mechanism through which AGO2 is involved in nucleosome 
positioning in mammalian cells.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
INTRODUCTION 
 
The Argonaute protein family 
  
Argonaute proteins constitute a highly conserved protein 
family whose number is much variable between species, 
ranging from one in S. pombe (Verdel et al., 2004) to 27 in 
C.elegans (Grishok et al., 2001). 
In mammals eight Argonaute proteins have been identified 
(Sasaki et al., 2003). 
These proteins are highly specialized binding modules that 
accommodate the small RNA component — such as 
microRNAs (miRNAs), short interfering RNAs (siRNAs) or 
PIWI-associated RNAs (piRNAs) — and coordinate 
downstream gene-silencing events by interacting with other 
protein factors. 
 
Structural features of AGO proteins 
 
Argonaute proteins are multi-domain proteins that contain an 
N-terminal domain, and a PAZ, middle (MID) and PIWI 
domain (Fig.I1a). The recent determination of the crystal 
structure of full-length human AGO2, consistent with previous 
studies of prokaryotic homologues, has revealed a bilobate 
architecture, with the MID and PIWI domains forming one 
lobe, and the N-terminal and PAZ domains constituting the 
other (Fig.I1b) (Schirle NT, 2012).  
The interaction between small RNAs and AGOs does not occur 
through sequence-specific contacts but through several contact 
points on the protein, mediated by distinct domains (Yan KS, 
2003). 
 
 
Fig. I1 A: Schematic representation of the Ago2 primary sequence. B: 
Front and top views of Ago2 with the N (purple), PAZ (navy), MID (green), 
PIWI (grey) domains and linkers L1 (teal) and L2 (blue). A generic guide 
RNA (red) can be traced for nucleotides 1–8 and 21. Tryptophan molecules 
(orange) bind to tandem hydrophobic pockets in the PIWI domain (Schirle 
NT, 2012). 
 
 In particular, the small RNA 5’ and 3’ termini are recognized 
by the PAZ and MID domains, respectively. The MID domain 
contains a highly basic pocket, which specifically binds the 
characteristic 5’ phosphate of sRNAs and anchors the sRNA 
onto Argonaute proteins (Ma JB, 2005). Once the sRNA has 
been loaded, Argonaute proteins silence target RNAs by slicing 
activity that resides in the PIWI domain. The PAZ domain 
contains a specific binding pocket that specifically recognizes 
the characteristic 2-nucleotide 3’ overhang and the base-paired 
terminus of siRNA duplexes produced by Dicer processing 
(Lingel et al., 2003). A segment of the human PIWI domain 
has been shown to mediate protein-protein interaction between 
Argonaute proteins and Dicer, which may facilitate the 
incorporation of the siRNA into the effector RNA silencing 
complex (Doi et al., 2003). 
The PIWI domain shows extensive homology to RNase H, an 
endoribonuclease that cleaves RNA–DNA hybrids (Parker JS, 
2004). In vitro assays using RNA substrates complementary to 
exogenous siRNAs (Liu J, 2004) as well as endogenous 
miRNAs (Meister G, 2004) have identified AGO2 as the only 
member of the human AGO subfamily with endonuclease 
activity. 
  
Sub-cellular localization of AGO proteins 
 
AGO proteins have been implicated in both post-transcriptional 
and transcriptional gene-expression regulation. This dual level 
of regulation reflects the localization of AGO both in the 
cytoplasm and in the nucleus. 
Previous studies have shown that AGO proteins are located in 
the nucleus of cells of yeast
 
(Verdel et al., 2004), plants 
(Zilberman et al., 2003),
 
Drosophila melanogaster (Pal-Bahdra 
et al., 2004) and human cell lines (Robb GB, 2005). 
 The distinct sub-cellular localization of AGO proteins is 
mediated by accessory proteins and post-translational 
modifications, which coordinate AGO activity with the 
plethora of cellular signals. In the cytoplasm AGO proteins are 
enriched in distinct foci such as P-bodies and stress-granules. 
The former are cellular sites where mRNA turnover and 
storage occur (Eulalio A, 2007a), the latter are structures 
induced upon cellular stress and contain mRNAs stalled in the 
process of translation initiation (Leung AK, 2006). It has been 
reported that the AGO2 P-body localization is mediated by 
several accessory proteins such as GW182 (Eulalio A, 2007b), 
and influenced by post-translational modifications such as 
phosphorylation at serine-387 (Zeng Y, 2008).   
Emerging evidence shows that the cytoplasmic and nuclear 
AGO2-functions are coordinated by a common set of proteins. 
Imp8, which is required for binding of AGO proteins to a 
variety of mRNA targets in the cytoplasm, modulates nuclear 
localization of AGO2 as well (Weinmann L, 2009). Similarly, 
TNRC6A, that interacts with AGOs and triggers translational 
repression and/or mRNA degradation in P-bodies, translocates 
AGO2 in and out the nucleus via its own recently discovered 
nuclear localization signals (NLS) and nuclear export signals 
(NES) (Nishi K, 2013).  
 
Loading of AGO Proteins with small RNAs 
 
Naturally produced dsRNAs may derive from several different 
sources. Molecules of dsRNA may emerge during viral 
infection and replication (Li et al., 2002;) or after transposition 
of mobile genetic elements (Ketting et al., 1999). Transcribed 
pseudogenes (Hirotsune et al., 2003), endogenous repetitive 
gene loci (Aravin et al., 2001) or microRNA genes (Bartel, 
2004-a) represent other endogenous sources of dsRNAs. 
Molecules of dsRNA are processed by Drosha and/or Dicer 
RNase III enzymes into small dsRNA of specific length and 
structure (Bernstein et al., 2001) which can enter into various 
gene silencing pathways that are collectively referred to as 
RNA silencing (Grishok et al., 2001).  
Ago proteins most likely recognize the characteristic 2 nt 3' 
overhangs of  small dsRNA  by their PAZ domains. 
Depending on the source of dsRNA, the products of Dicer 
processing are termed small interfering RNAs (siRNAs) or 
microRNAs (miRNAs). 
siRNAs. After Dicer-mediated cleavage, one strand of the 
siRNA duplex (the guide strand) is loaded in the RISC-loading 
complex (Hammond et al., 2000), a ternary complex that 
consists of an AGO protein, Dicer and a dsRNA-binding 
protein (known as TRBP in humans). During loading, the non-
guide (passenger) strand is cleaved and ejected.  
miRNAs. These small RNAs are transcribed by polymerase II 
from endogenous miRNA genes resulting in a primary 
transcripts (pri-miRNAs) that contain ~ 65–70-nucleotide 
stem–loop structures. The hairpin structure is excised in the 
nucleus by the Drosha–DGCR8 complex to yield a precursor 
miRNA (pri-miRNAs). After its export to the cytoplasm, the 
pri-miRNAs undergoes another endonucleolytic cleavage, 
which is catalysed by Dicer, generating a miRNA–miRNA* 
duplex of ~21–25 nucleotides (where miRNA is the guide 
strand and miRNA* is the passenger strand). For most 
miRNAs, only one strand accumulates as mature miRNA.  
Such asymmetric loading is guided by the relative 
thermodynamic stability of the 5’ ends of the small RNA 
duplex. The strand whose 5’ end is less stably paired is 
preferentially incorporated into AGO complexes, whilst the 
passenger strand is subsequently degraded (Bartel DP, 2009).  
 
Ago-Mediated Post-transcriptional Gene Silencing 
Pathways 
 
Sequence specific gene silencing triggered by double-stranded 
RNA (dsRNA) is a fundamental gene regulatory mechanism 
present in almost all eukaryotes (Béclin et al., 2002; Denli and 
Hannon, 2003; Dykxhoorn et al.,2003; Finnegan and Matzke, 
2003; Grewal and Moazed, 2003; Hannon, 2002; Plasterk, 
2002). Gene silencing mediated by dsRNAs has been shown to 
act at the post-transcriptional level.  
Depending not only on the bound small RNA but also on 
 the specific mRNA that is targeted, Ago protein complexes 
mediate different posttranscriptional gene silencing 
mechanisms.  
Post-transcriptional regulation. The mechanism by which a 
small RNA regulates its target mRNAs reflects both the 
specific AGO protein association and the extent of 
complementarity between the small RNA and the mRNA. In 
general, a full complementarity to target mRNAs, typical of 
siRNAs, directs endonucleolytic cleavage (slicing) of the 
mRNA (Elbashir et al., 2001). After slicing, the cleaved target 
RNA is released, and the RISC is recycled for another round of 
slicing (Zamore PD, 2001). (Fig. I2-b) 
miRNAs  not only can guide RNA cleavage (Llave et al., 
2002), but are predominantly considered to act as translational 
repressors on partially complementary, evolutionary conserved 
sequences in the 3’ UTR of the target mRNAs (Aukerman and 
Sakai, 2003).  
miRNAs generally interact with their mRNA targets through a 
limited base-pairing of only 2-7 nt (seed region) at the 5’end. 
With few exceptions, miRNAs-binding sites lie in the 3’UTR 
of target mRNA and are usually present in multiple copies.  
Typically, mRNA may have several putative targets for both 
the same and different miRNAs, and any particular miRNA 
may have hundreds of putative mRNA targets. Hence, given 
the substantial number of miRNAs, a big combinatorial 
network of miRNA-mediated post-transcriptional gene 
regulation exists (Selbach M, 2008).  
Since their initial identification in 1993 (Lee RC. et al., 1993), 
there have been several efforts for the identification of miRNA 
targeted genes and computational target prediction remains one 
of the key means to analyse the role of miRNAs in biological 
processes. Therefore, many miRNA target prediction programs 
have been published, such as TargetScan (Lewis et al., 2005), 
Pictar (Lall et al., 2006) and Diana-microT (Maragkakis et al., 
2009). Most of these programs are mainly based on sequence 
alignment of the miRNA seed region (nucleotides 2–7 from the 
5′-end of the miRNA) to the 3′-UTR of candidate target genes 
leading to the identification of putative binding sites. 
 
 
Fig I2: a. Short interfering (si)RNAs. Molecular hallmarks of an siRNA 
include 5′ phosphorylated ends, a 19-nucleotide (nt) duplexed region and 2-
nt unpaired and unphosphorylated 3′ ends that are characteristic of RNase 
III cleavage products14. b. The siRNA pathway. Long double-stranded 
(ds)RNA is cleaved by Dicer, into siRNAs in an ATP-dependent reaction. 
siRNAs are then incorporated into the RNA-inducing silencing complex 
(RISC). Although the uptake of siRNAs by RISC is independent of ATP, 
the unwinding of the siRNA duplex requires ATP. Once unwound, the 
single-stranded antisense strand guides RISC to mRNA that has a 
complementary sequence, which results in the endonucleolytic cleavage of 
the target mRNA. c |The micro (mi)RNA pathway. Although originally 
identified on the basis of its ability to process long dsRNA, Dicer can also 
cleave the ~70-nt hairpin miRNA precursor to produce ~22-nt miRNA. 
They target mRNA leading to translational repression.  
(Dykxhoorn et al.,2003). 
 
 
 
 Their specificity is usually increased by exploiting the 
commonly observed evolutionary conservation of the binding 
sites or by using additional features such as structural 
accessibility (Kertesz et al., 2007), nucleotide composition 
(Grimson et al., 2007) as well as location of the binding sites 
within the 3′-UTR (Gaidatzis et al.,2007).  
Degradation of mRNAs associated to AGO-miRNA complexes 
involves deadenylation (removal of the poly(A) tail) (Eulalio 
A, 2007c), and/or decapping (removal of the 7-
methylguanosine cap structure) (Rehwinkel J, 2005). The 
exposure of mRNA termini leads to exonucleolytic digestion 
from the 5’ and 3’ends by the action of the exosome and of the 
exonuclease XRN1, respectively (Parker R, 2004b). miRNAs 
might also silence their targets by sequestering mRNAs into P-
bodies, which exclude the translation machinery, and releasing 
them upon specific signals allowing the re-enter into 
polyribosomes fraction for translation (Bhattacharyya SN, 
2006).  
Transcriptional regulation. In addition to their post-
transcriptional role in the cytoplasm, AGO proteins also 
function in the nucleus either repressing or activating 
transcription (Gagnon KT, 2012). In humans, the existence of 
nuclear RNAi pathways was first inferred from observations 
that nuclear miRNAs and siRNAs could cause cleavage of 
RNA targets, such as 7SK small nuclear RNA (Robb GB, 
2005). In addition, endogenous human AGO2 was identified in 
the nucleus with highly specific antibodies (Rudel S, 2008). 
The first report of human transcriptional gene silencing (TGS) 
utilized exogenous siRNAs to silence expression of an 
integrated GFP reporter driven by the eukaryotic translation 
elongation factor alpha (EF1α) promoter (Morris KV, 2004). 
The silencing at transcriptional level was confirmed by nuclear 
run-on analysis, which is the gold standard for differentiating 
silencing effects mediated by TGS from those of the post-
transcriptional pathways.  
Subsequently, other reports described the silencing of various 
genes, including E cadherin, RASSF1, TGFb receptor II, 
progesterone receptor, major vault protein, androgen receptor, 
cyclooxygenase-2, CDH1, and c-myc (Ting AH, 2005; 
Castanotto D, 2005; Janowski BA, 2007; Kim JW, 2007; Green 
VA, 2011). Mechanistic details about TGS have begun to 
emerge after the observation that siRNA-induced silencing at 
the EF1α promoter was sensitive to the Pol II inhibitor α-
amanitin (Weinberg MS, 2006). This observation led to the 
proposal of two models to explain the mechanism of TGS: (a) 
the siRNA binds to DNA, facilitated by the opening of the 
DNA duplex by the transcription machinery; (b) the siRNA 
binds to nascent promoter-associated RNA. Work by Han et al. 
favoured the latter by revealing a requirement for a promoter-
associated transcript for small RNA-mediated gene silencing 
(Han J, 2007). The antisense strand of the siRNA was shown to 
target an EF1α promoter-associated RNA variant with an 
extended 5’UTR. In addition, the association was inhibited by 
RNase A but resistant to RNase H treatment, implicating an 
RNA-RNA interaction in TGS.  
Other studies have also demonstrated a requirement for 
promoter-associated transcripts for small RNA-mediated gene 
silencing. Some of these studies have shown that, similar to 
EF1α, silencing requires sense strand transcripts (Hawkins PG, 
2009), while others have found that antisense transcription 
through the targeted region is necessary (Schwartz JC, 2008). 
The findings reported to date, support a model for TGS in 
which AGO2-small RNAs complexes are guided to their 
targets by complementary base-pairing with low copy, 
promoter-associated Pol II transcript.  
AGO2 serves as a scaffold for the recruitment of chromatin-
modifying complexes that favour heterochromatin formation 
and, therefore decreasing transcription of the targeted gene 
(Hall et al., 2002). More recently, small RNA-targeting of 
sequences beyond the mRNA 3’terminus of the PGR gene has 
been demonstrated to induce TGS (Yue X, 2010). Targeting 
genomic regions outside promoter sequence involves a looping 
mechanism bringing the 3’ terminus and the promoter into 
close proximity to allow modulation of promoter activity. The 
report of transcriptional gene activation (TGA) showed 
increase expression of E- cadherin, p21, and VEGF on the 
transfection of promoter-targeting siRNAs into cultured cells 
(Li LC, 2006). The mechanism by which transcriptional 
activation is achieved shares common features with the 
transcriptional silencing. The transcriptional opposite outcome 
depends on the specific region targeted by the small RNA and 
by the different set of modifying complexes recruited. 
Emerging evidence has revealed that the TGA/TGS in human 
cells can be mediated not only by exogenous small RNA but 
also by endogenous ones. Consistently, it has been reported 
that a substantial fraction of human miRNAs are present in the 
nucleus, with even an abundance greater than their cytoplasmic 
levels, and, in some cases, have shown to alter promoter 
activity (Kim DH, 2008; Place RF, 2008). It is the case of miR-
373 and miR-320, in which the former induces and the latter 
represses transcription (Place RF, 2008) (Kim DH, 2008). 
Moreover, endo-siRNAs with a putative role in transcriptional 
regulation have been recently discovered also in mammals 
(Yang N, 2006). Many are the genomic sources of dsRNA 
triggering for endo-siRNAs: structured loci that pair intra-
molecularly to produce long dsRNA, complementary 
overlapping transcripts and bidirectionally transcribed loci, 
protein-coding genes that associate with the cognate 
pseudogenes and from regions of pseudogenes that form 
inverted repeated structures (Ghildiyal M, 2009).   
 
 
SWI/SNF chromatin re-modeller complexes 
 
DNA storage and chromosome packaging are important 
biological processes common to all living organisms. In 
eukaryotes, the advent of nucleosome-based DNA organization 
not only promoted favourable packing ratios that increase 
cellular DNA content but also facilitated the development of 
complex regulatory mechanisms. The basic unit of chromatin is 
the nucleosome, which consists of 146 base pairs of duplex 
DNA wrapped around a histone octamer comprised of two of 
each of the conventional histone proteins: H2A, H2B, H3 and 
H4. Highly related histone variants are also incorporated 
throughout the genome for regulatory purposes (Talbert PB, 
2010). A fifth histone protein, H1, promotes higher order 
chromatin structures by encouraging condensation of 
neighbouring nucleosomes from “beads on a string” to the 30 
nm fibre. As this resulting fibre accounts for only ~25-fold of a 
5000- fold DNA-to-nucleus compaction ratio, several other 
mechanisms must contribute to higher order compaction and 
nuclear organization. Inherent to any packing solution is the 
need for reversibility, as DNA must remain accessible to 
cellular machinery as required. To accomplish this task, 
chromatin re-modelling proteins form crucial complexes that 
reposition nucleosomes. They utilize the energy of ATP to 
disrupt nucleosome-DNA contacts, move nucleosomes along 
DNA, and remove or insert histone octamers.  
The best-studied family of chromatin remodeler is the 
evolutionarily conserved SWI/SNF family (Clapier CR, 2009). 
In mammals, these enzymes play an essential role in several 
aspects of embryonic development including pluripotency (Yan 
et al., 2008), cardiac development (Hang et al., 2010), dendritic 
morphogenesis  (Kim JK et al., 2001) and self-renewal of 
neural stem cells (Kidder et al., 2009). In the adult, deletion or 
mutation of these proteins often leads to tumorigenesis as a 
consequence of a dysregulated cell cycle control (Weissman B, 
2009). The SWI/SNF family of chromatin re-modellers spans 
eukaryotic lineages. Purified SWI/SNF complexes contain 10–
12 polypeptides and have an apparent molecular mass of ∼2 
MDa in mammals (Wang et al., 1996). SWI/SNF complexes in 
mammalian cells contain one of two possible ATPases (Brg1 
or Brm). 
Human SWI/SNF subunits are often encoded by more than one 
gene, thus permitting combinatorial assembly and a diversity of 
related complexes, some of which are modulated during 
development and cell differentiation.  
Canonical human SWI/SNF complexes contain a single 
ATPase, a “core” group of subunits consisting of Ini1 
(integrase interactor 1), BAF155 (Brg1-associated factor), and 
BAF170, plus seven other accessory subunits, one of which is 
β-actin. Four of the accessory subunits are each encoded by a 
different gene family that has between two and four members, 
thus permitting 72 possible combinations among them when 
allowing for one protein from each family per SWI/SNF 
complex (Wu et al., 2009). In mammalian cells, the SWI/SNF 
family can be divided into BAF and PBAF subfamily (Fig. I3). 
  
 
FIG I3: Mammalian SWI/SNF chromatin-remodeling complexes are 
subdivided into BAF and PBAF complexes. BAF complexes are defined by 
either BAF250A or BAF250B as the ARID-containing subunit (light green 
ovals), which are mutually exclusive (as denoted by dashed arrow with dual 
arrowheads), while PBAF complexes utilize BAF200 (blue oval) as the 
ARID-containing subunit. PBAF complexes also incorporate BAF180 (blue 
oval), which has 6 bromodomains that can bind to acetylated histones. BAF 
complexes are catalyzed by either BRG1 or BRM (red ovals), but no single 
complex contains both as denoted by dashed arrow with dual arrowheads. In 
contrast, PBAF is catalyzed exclusively by BRG1 (red oval). A number of 
other common subunits (BAFs for BRG1 or BRM associated factors) are 
also present (gray ovals from largest to smallest with numbers referring to 
protein size in KDa), and some of these subunits are represented by multiple 
isoforms (as indicated by asterisks) that are encoded by separate genes 
although only 1 isoform is present in a single complex similar to BAF250A-
BAF250B and BRG1-BRM. (Bevilacqua et al., 2013) 
 
This subdivision is due to the exclusive presence of ARID1a-b 
only in BAF complexes and BAF180, BAF200, and BRD7 in 
PBAF complexes. These exclusive subunits provide functional 
specificity recruiting the complexes to specific loci and the 
association with specific proteins (Nie Z, 2000; Thompson M, 
2009).   
Both cellular and developmental contexts are highly important 
when considering the composition of SWI/SNF, as well as its 
eventual targets and actions. For example, specialized 
SWI/SNF complexes, such as those found in embryonic stem 
(ES) cells, include Brg1, BAF155, and BAF60A but exclude 
Brm, BAF170, and BAF60C (Kaeser et al., 2008; Ho et al., 
2009). Notably, the majority of SWI/SNF subunits are capable 
of binding to DNA or chromatin. DNA-binding domains found 
among various SWI/SNF subunits include HMG, ARID (AT-
rich interaction domain), SANT, and Krüppel domains (Wu et 
al., 2009). Binding appears to lack sequence specificity; 
however, recognition of certain DNA structures may be 
favoured, such as the minor groove of DNA and four-way 
helical junctions (Das et al., 2009).  
Epigenetic modifications also contribute to SWI/SNF and 
chromatin associations. Bromodomains, found in both of the 
ATPases and in several other SWI/SNF subunits, are thought to 
recognize acetylated lysines in histones (Singh et al., 2007). 
BAF155 and BAF170 each contain a chromo-related domain, 
which suggests a high affinity for methylated histones (Brehm 
et al., 2004). Indeed, the SWI/SNF complexes are defined 
polymorphic readers of epigenetic modifications (Wu JI, 
2009). Moreover, their large size (about 12-fold bigger than a 
nucleosome) should enable reading of multiple histone 
modifications on adjacent nucleosomes providing significant 
affinity for both targeting and retention. Conversely, the 
indirect recruitment involves protein-protein interaction with 
histone modifying complexes (Zhang HS, 2000) and with 
transcriptional activators and repressors such as p53 (Lee D, 
2002), cyclin E (Shanahan F, 1999), nuclear hormone receptors 
(Trotter KW, 2008). In the formation of productive SWI/SNF 
complexes, stochastic assembly and transient interactions 
among subunits may also play a significant role, as has been 
proposed for other large protein complexes, such as RNA 
polymerases and associated transcription factors (Dinant et al., 
2006), spliceosomes (Rino et al., 2007), and DNA repair 
complexes (Luijsterburg et al., 2010). 
Functions of SWI/SNF 
One of primary functions of SWI/SNF complexes is to assist in 
gene regulation. The combination of ChIP with either DNA 
microarrays (ChIP-chip) or, more recently, sequencing (ChIP-
seq) enables the genome-wide localization of chromatin-
associated proteins. Several recent studies highlight the use of a 
genomic approach in elucidating regulatory regions associated 
with SWI/SNF localization patterns.  
Euskircken et colleagues (2011) have recently identified the 
targets of four SWI/SNF components, Ini1 (SMARCB1), Brg1 
(SMARCA4), BAF155 (SMARCC1) and BAF170 
(SMARCC2), using ChIP-Seq experiments followed by 
bioinformatics data analysis with PeakSeq (Rozowski et al., 
2009). Such genome-wide analysis of SWI/SNF binding sites, 
conducted in HeLa S3 cell lines, indicates that SWI/SNF 
complexes likely contribute to gene regulation through many 
different avenues. In fact, SWI/SNF complexes are reported to 
bind promoters, enhancers, CTCF sites and many regions 
occupied by Pol II (Euskirchen GM, 2011). 
Furthermore, SWI/SNF complexes may facilitate looping 
interactions among these various elements. It has been shown 
in vitro that SWI/SNF can interact simultaneously with 
multiple DNA sites and generate loops between them (Bazett-
Jones DP, 1999). DNA looping plays a significant role in gene 
regulation on a system-wide level by bringing linearly distant 
regions into close spatial proximity. Chromosomal looping 
interactions have been mapped at high resolution in vivo using 
3C (chromosome conformation capture) and related methods. 
Examples of SWI/SNF-mediated higher order chromatin 
interactions are loops that can form in the β-globin locus 
control region (Kim S. et al., 2009, a), in the α-globin locus 
(Kim S. et al., 2009, b), throughout regions of the 200-kb T 
helper 2 (Th2) cytokine locus (Cai et al., 2006), and across the 
150-kb CIITA locus (Ni et al., 2008). 
Once targeted to specific promoters or enhancers, SWI/SNF 
complexes promote transition to and from the active and 
repressed chromatin state. These opposite effects are mediated 
by interactions with different types of co-regulators. For 
example, SWI/SNF complexes interact with MYC, a 
transcription factor that regulates gene expression during cell 
cycle progression, apoptosis and differentiation. In particular, 
the core subunit SNF5 directly interacts with MYC and is 
capable of cooperating in the activation of MYC target genes in 
vitro (Cheng SW, 1999). By contrast, the ATPase subunits 
BRG1 binds to RB and facilitates the repression of RB target 
genes, including E2Fs and CCND1 (Trouche D, 1997). 
Transcriptional activation by SWI/SNF complexes is achieved 
by sliding or ejecting nucleosomes, allowing the transient 
exposure of binding sites for transcriptional activators and the 
stabilization of pre-initiation complex formation (Salma N, 
2004). Additionally, SWI/SNF have been shown to be 
associated with regions downstream the promoter and to 
influence the RNA Pol II promoter escape (Soutoglou E, 2002) 
and transcription elongation (Corey LL, 2003).  
On the contrary, SWI/SNF represses transcription inducing a 
more compact chromatin conformation and also allowing 
transcriptional repressors to bind to chromatin or facilitating 
other modifications of the chromatin such as deacetylation of 
histones (Sudarsanam and Winston; 2000). Besides its role in 
transcriptional regulation, recent findings illustrate that 
SWI/SNF act also post-transcriptionally regulating the 
production of alternative transcripts.  
SWI/SNF interacts with components of the nascent pre-mRNA 
complex and with the transcription machinery (Cho H, 1998). 
These interactions cause a delay in the transcription elongation 
rate, which in turn affects splice site selection. Moreover, 
SWI/SNF associates with several components of the 
spliceosome and with Sam 68, an ERK-activated enhancer of 
variant exon inclusion (Batsché E, 2006). The post-
transcriptional regulation of SWI/SNF seems to be independent 
from its chromatin remodelling activity. In fact, mutation of the 
ATPase domain of hBrm does not impair its effect on splicing 
regulation (Batsché E, 2006).  In order to better understand the 
very complex network of SWI/SNF cellular functions, 
proteomic analysis in human and mouse cell lines were 
exerted. 
Immunoprecipitated proteins from non-cross-linked HeLa cells 
were identified by MS for six different SWI/SNF subunits: 
Brg1, Brm, Ini1, BAF155, BAF170, and BAF250A. 
Comprehensive analysis of SWI/SNF-interacting proteins 
revealed the presence of transcription factors, DNA repair 
proteins (ERCC5 and RAD50), DNA replication proteins 
(MCM2 and RPA1), and proteins important for chromosome 
integrity (NUF2, BUB1B, CENP-E, and PTTG1) (Euskirchen 
et al., 2011). In total, 158 SWI/SNF-interacting proteins have 
been described in HeLa cells across numerous studies from 
multiple investigators (Euskirchen et al., 2011), and ∼200 
SWI/SNF-interacting proteins have been described in mouse 
ES cells, including histone- and DNA-modifying enzymes and 
regulators (e.g. HDAC1, JARID2, DNMT3b, and DNMT3L) 
(table2) (Ho et al., 2009) (Table 2). 
 Table 2: Histograms showing the frequencies of UniProt keywords for 
proteins that co-purify with SWI/SNF factors. The keywords shown were 
retrieved from the UniProt Database for proteins that co-purify with a 
SWI/SNF factor for HeLa cells (A) and mouse ES cells (B;). Multiple 
(Euskirchen et al., 2012) 
PREVIOUS RESULTS 
 
In our laboratory AGO2-associated proteins have been 
investigated by SILAC/MS approach. As expected, well-
known AGO2 interactors, such as TNRC6 complex (Pfaff et 
al.,2013) and HSP90 (Wu et al., 2011) were enriched in AGO2 
immunoprecipitates (AGO2-IP) relative to mock IP (IgG-IP). 
Surprisingly, as shown in the Table P1, from our proteomic 
analysis emerged several nuclear proteins that were not known 
to be associated to AGO2.  A Gene Ontology analysis revealed 
that, besides the cytoplasmic complexes such as RISC 
complex, AGO2 is also bound with high significance to many 
nuclear complexes implicated in mRNA processing (mRNA 
cleavage and polyadenylation) and in chromatin remodelling. 
Indeed, our results revealed for the first time the association of 
AGO2 to the main family of chromatin-remodelling 
complexes: the SWI/SNF family. Among the most highly 
enriched proteins in our AGO2-immunoprecipitations we 
found all the core proteins of SWI/SNF complexes (BAF155, 
BAF170, SNF5), both the ATPase subunits (BRG1 and BRM) 
and several accessory proteins including the subunits signature 
of BAF (ARID1a-b) and PBAF complexes (BAF180) (Table 
P1). 
  
 
 
Table P1: SILAC/MS results. Top-list of AGO2-associated proteins 
ranked on fold enrichment over the control immunoprecipitation. 
 
 
 We further validated that AGO2 and SWI/SNF associate in 
vivo through immunoprecipitation and western blotting 
experiments on HeLa S3 cells (Fig. P2). Moreover, this 
association is independent of RNA molecules and involves a 
protein-protein interaction (Fig. P3). Our experiments 
demonstrated that only AGO2 and not AGO1 specifically 
interacts with SWI/SNF complexes (data not shown). 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
 
 
 
 
 
 A.    B. 
Fig P4: AGO2 and SWI/SNF complexes interact in the nucleus. (A)  
Control of cell fractionation by blotting for GAPDH and H1, cytosol and 
nuclear marker respectively. (B) AGO2-BAF155 co-immunoprecipitation 
from the nuclear fraction of HeLa S3 cells. 
 
 
 
FIG P2: Human AGO2 interacts with SWI/SNF subunits BAF155 
and BRG1. (A) HeLa S3 whole cell extracts were 
immunoprecipitated using anti-AGO2 or IgG (negative control) and 
analysed by western blotting using antibodies anti-BAF155 (core 
subunits) and anti-BRG1 (one mutually exclusive ATPase). (B) 
Reverse co-immunoprecipitation using BAF155 antibody was blotted 
with anti-AGO2. 
 
 
FIG P3:  AGO2-SWI/SNF complexes interaction is RNA 
independent.  Total cell extract (treated or not with RNase A) were 
immunoprecipitated with a monoclonal antibody against AGO2 
(AGO2_IP) or isotype-matched immunoglobulins (IgG_IP) as a negative 
control. Input and immunoprecipitates (IP) were analyzed by western 
blot for the presence of AGO2 and BAF155 proteins. 
 As shown in Fig. (P4) SWI/SNF-AGO2 interaction has been 
confirmed also in the nucleus, besides the validation performed 
on whole cell extracts (FIG P3). To this aim, a cell 
fractionation into cytosolic and nuclear fraction was performed, 
followed by AGO2 immunoprecipiation from the nuclear 
fraction only. The association with BAF155 was verified by 
western blot. 
Furthermore, a chromatin fractionation experiment was 
performed (Fig. P5) to assess whether AGO2 is associated with 
chromatin. The AGO2 and BAF155 distribution profiles 
through the several resulting fractions were compared. 
As expected, AGO2 was mainly detected in the S1 fraction, 
that includes the cytosolic and nucleoplasmic components. 
Interestingly, a substantial amount of AGO2, as well as 
BAF155, was revealed also in S2 fraction that specifically 
represents proteins associated to chromatin. 
 
 
 
 
 
 
 
 
 A.    B. 
 
Fig P5. (A) Scheme of the procedure used to fractionate HeLa S3 cells 
(Cernilogar FM, 2011). Chromatin associated proteins should be found in 
fractions P1 (pellet) and S2 (supernatant). (B) AGO2 is associated with 
chromatin in the nuclei of human cells. Equal amounts of each resulting 
fraction was analyzed by western blotting for the presence of the indicated 
proteins. Tubulin (TUB) serves as a chromatin unbound marker, whereas 
H1 is a chromatin bound marker that is fully released only after high salt 
and DNase treatment.  
 
 
In conclusion, these data suggested us that AGO2-SWI/SNF 
complexes might co-operate at chromatin level. 
 
 
AIM OF THE THESIS 
 
Studies over the past years have provided strong evidence 
regarding the multi-level regulation of gene expression 
operated by AGO proteins. In particular, human AGO2 protein, 
the only endonucleolytically active AGO protein, has been 
demonstrated to act either post-transcriptionally or at 
transcriptional level. In order to exert this multiplicity of roles, 
AGO2 needs to associate to different proteic and/or ribonucleic 
partners (sRNAs). As previously demonstrated in our 
laboratory, AGO2 interacts with SWI/SNF complexes in nuclei 
of human cell lines. Therefore, as SWI/SNF is the most 
important chromatin-remodelling complex, these findings 
could suggest that AGO2 has an active role in chromatin 
plasticity. In order to shed light on AGO2 possible roles in 
chromatin remodelling processes, I set up an extensive 
bioinformatics pipeline analysis aiming at the characterization 
of the small RNAs loaded onto nuclear AGO2 by high-
throughput technologies. The outcome of my bioinformatics 
analysis indicates the existence of a novel, uncharacterised 
class of AGO2-bound sRNAs. Further analyses have then been 
conducted in order to investigate their biogenesis and 
molecular functions.  The questions I will try to address regard 
the processing mechanisms they undergo, their possible 
involvement in mRNA expression level changes  the 
correlation between this novel class of sRNAs and SWI/SNF, 
and least but not last, their possible involvement in nucleosome 
positioning. From this extensive bioinformatics analysis, I have 
been able to identify new biological processes AGO2 is 
involved in. 
 
RESULTS 
 
Analysis of nuclear AGO2-associated small RNAs 
 
The interaction of AGO2 with SWI/SNF complexes prompted 
us to hypothesize a concerted role of AGO2 and SWI/SNF in 
chromatin dynamics and possibly in gene expression 
regulation. Recently, it has been shown that in HeLaS3 cells 
SWI/SNF is recruited in the proximity of TSS of expressed 
genes (Euskirchen et al., 2011). The current model for gene 
expression regulation exerted by AGO2 indicates that AGO2 
utilizes small RNAs (sRNAs) to recognize target molecules 
(Elbashir et al., 2001; Liu et al., 2004; Meister et al., 2004).  
Moreover, there is evidence of the existence of a class of 
sRNAs arising from sense and antisense strand nearby TSS 
(TSSa RNA) (Seila et al., 2008; Valen et al., 2011). Starting 
from these considerations, I speculated whether AGO2 is 
loaded with TSSa RNAs in the nuclei of human cells. 
Therefore, we performed an RNA Immunoprecipitation in 
order to profile by Next Generation Sequencing (NGS) the 
nuclear AGO2-bound sRNAs in HeLaS3. As control, a parallel 
immunoprecipitation using isotype matched IgG was 
performed. RNAs extracted from the total nuclear RNA sample 
(Input) and from the IPs samples were subjected to deep-
sequencing. Two independent biological replicates were 
performed.  
Samples were sequenced on an Illumina HiSeq2000 machine. 
The sequencing experiment produced the following amount of 
data:  
151.830.408 short reads (sequences 50 nucleotides in length) 
for the input sample; 
• 149.821.287 short reads (sequences 50 nucleotides in 
length) for the AGO2-IP sample; 
• 87.923.967 short reads (sequences 50 nucleotides in 
length) for the IgG-IP sample. 
The term read refers to a short cDNA sequence, typically as 
output by a sequencing instrument. A corresponding string of 
quality values usually accompanies a read, where each value 
estimates the probability that the corresponding base was 
miscalled by the instrument software. 
The analysis and biological interpretation of the huge amount 
of data obtained from this deep-sequencing experiment required 
me to set up a bioinformatics pipeline.  
The first step of my bioinformatics analysis was the quality 
check through FASTQC 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/), a 
bioinformatics tool providing a simple way to do some quality 
control checks on raw sequence data coming from high 
throughput sequencing pipelines.  
After checking a good status of the experiment, I removed the 
adaptor sequences with Cutadapt (Martin, 2011). Indeed, when 
sequencing devices produce a list of sRNAs sequences, often 
the read length exceeds the length of the sRNA itself. 
Depending on the device, this can result in sequenced reads 
that include  sequences of the adaptor nucleic acid molecules 
employed in the cloning procedure at one or both ends of the 
read. The Adaptor Removal tool trims away these adaptor 
sequences making sRNAs data ready for analysis and 
processing by other tools.  
At this point, I proceeded with the phase of the mapping, which 
means assessing which genomic regions the reads arise from. 
The Bowtie (Langmead et al. 2009) bioinformatics tool enables 
the alignment of large sets of sequencing reads to a reference 
sequence, such as the human genome. Bowtie has many 
command-line options that allow the user to tune its behaviour 
according to the inputs and the desired result. 
To get a complete view of the general origin of these sRNAs, I 
pre-filtered the data against highly expressed sRNA species 
that would otherwise obscure any other lowly expressed novel 
class of sRNAs. Therefore, the reads were iteratively aligned to 
different databases of known AGO2-associated classes of 
sRNA. After each alignment round, reads with no alignments 
were used in the next step. Alignments were performed 
requiring no mismatches in the first 18 nt of the reads (the 
“seed” region).  Indeed, several authors have reported that this 
seed part of a read is expected to contain less miscalled bases 
due to the specifics of the NGS technologies (Nakamura et 
al,2011). 
During the alignment round, reads were aligned to miRbase 
(v20.0) to remove all reads aligning to human miRNA 
precursors.  
In a second step, unaligned reads were aligned against rRNA 
and tRNA database to remove any reads aligning to tRNA and 
ribosomal RNA.  
In a third step, unaligned reads were aligned against a manually 
cured Rfam database, a resource for RNA family information 
and multiple sequence alignments. Such manually cured Rfam 
database contains all sequences included in Rfam with the 
exception of those annotated as lincRNAs. 
After these pre-filtering steps, unaligned reads were mapped 
against the human genome (hg19) index.  
Some genomes, including the human genome, have substantial 
repetitive content (Batzer et al.,2002; Jurka et al., 2007; Britten 
et al. 2010; Hua-Van 2011;  Kim P., et al., 2008), i.e. sub-
sequences that appear multiple times throughout the genome. 
Repeats come in several forms (e.g. simple repeats, tandem 
repeats, segmental duplications, interspersed repeats), and arise 
via various biological processes (e.g. slipped strand mispairing 
or retro transposition). Repeats also affect alignments because 
reads originating from repetitive portions of the genome are 
difficult or impossible to unambiguously assign to a point of 
origin. Reads from repeats will tend to have many “valid” 
alignments, with no strong basis for preferring one over the 
others. Repetitive alignments in turn affect downstream 
analyses. The simplest way to deal with alignment ambiguity is 
to use Bowtie’s −m option to filter out and/or annotate 
ambiguous evidence as such. With the −m 1 option, I specified 
a limit whereby alignments for reads that aligned to more than 
one genomic location were excluded from the output. 
It is worth mentioning that no significant enrichment in 
Multiple Matching (MuM) reads was observed in AGO2 
sample compared to Input and IgG, ruling out the possibility 
that nuclear AGO2 preferentially binds repetitive sequences. 
Therefore, only RNAs mapping to a single locus on hg19 
genome assembly were further analysed, on the contrary 
Multiple Matching reads (MuM) were no longer investigated. 
The reads which uniquely mapped to hg19 have been called 
“other sRNAs” because they do not belong to any known class 
of sRNA. A closer look at “other sRNAs” revealed that they 
mostly occur as clusters consisting of less than 50 molecules 
with slightly different 3' and 5' termini (Fig R1). A few clusters 
(0.86%) consisted of hundreds to thousands of identical sRNAs 
(“High copy” clusters). These “high-copy” clusters likely 
represent novel miRNAs or PCR artefacts. In order to avoid 
any possible bias, I focussed my analysis on “low copy” 
clusters (99.14 % of clusters) only. 
 
 
 
 
 
 
 
 
 
 
 
 
FIG R1: cluster division. “Other sRNAs” were divided in clusters 
(requiring same strandness) using mergeBed bioinformatics tool; most 
clusters consisted of less than 50 sRNAs, while a few hundred clusters 
consisted of tens of thousands of identical reads. These high-copy clusters 
likely represent novel miRNAs or PCR artefacts. I therefore decided to 
focus my attention on sRNAs in low copy clusters (< 50 sRNAs) and 
removed reads lying into High-copy clusters (> 50 reads). 
 
 
The percentages of different classes of non-coding sRNAs 
observed in the mock sample and in the AGO2-IP sample are 
depicted in Fig.R2.  
As expected, the main class of sRNA in the AGO2 sample is 
represented by miRNAs. This specific miRNAs enrichment 
underlines the efficiency of our AGO2 immunoprecipitation, as 
miRNAs constitute the principal class of non-coding RNA 
associated to AGO proteins.  
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FIG R2: Genomic annotation of sRNA-Seq data. The histograms 
illustrate the sRNA classes identified in AGO2- or IgG-IP samples. The 
main RNA classes in the AGO2-IP sample are represented by miRNAs 
followed by “other sRNAs”. 
 
It is worth mentioning that, when ranking the four classes 
based on their abundance, the class of “other sRNAs” ranks 
second after miRNA class only in the AGO2-IP sample. 
To evaluate whether “other RNAs” may have a functional role 
or were to be considered purely background noise, a size 
distribution analysis was performed (Fig. R3). The size range 
considered was from 18 to 50 nt, where 18 is the minimum 
length required for alignment during the mapping step and 50 
is the sequencing length.  
 
 
 
 
 
 
 
 
 
 
 
 
 
FIG R3: Size distribution of AGO2- and IgG-IP “other sRNAs”. The 
fraction of “other sRNAs” in AGO2- or IgG-IP samples and corresponding 
length (nt) are plotted.  
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The “other RNAs” of the IgG-IPed sample showed a 
homogeneous distribution in the considered range. Intriguingly, 
the AGO2-IPed “other RNAs” displayed a size peak of 22-23 
nt which represents the canonical length of small RNAs bound 
to AGO proteins. This result suggests that “other sRNAs” do 
not represent degradation products or aspecific materials.  
In order to exclude the idea that these “other” RNAs could be 
putative miRNAs I performed a miRNA discovery analysis 
using miRanalyzer (Hackenberg et al., 2009). miRanalyzer is a 
web server tool very useful in the prediction of new 
microRNAs. This bioinformatics tool firstly clusters the input 
reads into putative mature microRNAs, then extracts candidate 
pre-microRNAs from the genome to select the energetically 
best candidate and finally applies five different Random Forest 
models (Breinman L., 2001) to calculate the probability that a 
given candidate is a microRNA (Hackenberg et al., 2011). 
MiRanalyzer did not report any candidate among AGO2 
associated “other sRNAs”, thus corroborating the idea of a 
novel and uncharacterised class of non-coding sRNAs 
associated to AGO2.  
In light of this finding, I proceeded to analyse how the newly 
identified sRNA class was distributed along the genome. Given 
the evidence of the existence of a class of short RNAs  of 
heterogeneous length arising from sense and antisense strand 
nearby TSS (TSSa RNAs) (Seila et al., 2008; Valen et al., 
2011), I looked for occurrence of TSSa RNAs among the class 
of “other sRNAs” identified in my samples.  
Therefore, using a bioinformatics tool called intersectBed 
(from BedTools package: Quinlan and Hall, 2010) I could 
intersect the genomic coordinates of my reads with the 
genomic coordinates of 1kb window around TSS of expressed 
genes. This step allowed me to compute the fraction of “other 
sRNAs” with at least a nt of overlap with a 1kb window around 
each TSS. 
As shown in Fig. R4-a, I found a specific enrichment of sRNAs 
mapping on TSS in AGO2-IP relative to mock-IP (P-value < 
2.2×10-16, exact binomial test; the frequency of overlapping 
“other sRNAs” was used as null hypothesis).   
As in our laboratory it was previously shown that AGO2 and 
SWI/SNF physically interact in the nuclei of HeLa S3 cell 
lines, I wanted to test whether there was a specific enrichment 
of “other sRNAs” lying within 1kb of SWI/SNF-bound 
regions.  With this aim, the genomic coordinates of clusters of 
each sample (AGO2-IP and IgG-IP) were intersected with the 
genomic coordinates of SWI/SNF binding sites obtained 
through ChIP-seq experiments (Euskirchen et al., 2012) in 
HeLa cell lines and the number of sRNAs overlapping 
SWI/SNF binding sites was computed. Intriguingly, “other 
sRNAs” mapping to SWI/SNF binding sites are enriched in 
AGO2-IP compared to mock-IP (P-value < 2.2×10-16, exact 
binomial test) (FigR4-b). 
    A.     B. 
  
 
 
 
 
 
 
 
 
 
 
 
FIG. R4: a. Percentage of “other sRNAs” in AGO2- or IgG-IP samples 
mapping within 1 kb of TSS of expressed genes. Only “other sRNAs” 
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lying within clusters of < 50 molecules were considered. b. Percentage of  
“other sRNAs” in AGO2- or IgG-IP samples mapping within SWI/SNF 
biding sites (ENCODE ChIP-seq data). Only “other sRNAs” lying within 
clusters of < 50 molecules were considered. 
 
 
Coverage analysis of TSSa RNAs on SWI/SNF-bound TSS 
(ENCODE ChIP-seq data) and all other TSS was then 
computed with coverageBed bioinformatics tools. using 
CoverageBed tool, I computed coverage of “other sRNAs” 
along a 1kb interval around each TSS, then processed the 
output in a custom perl script to obtain a cumulative coverage 
for all TSS of interst and finally plotted the results with R 
statistical environment (CRAN project: http://www.r-
project.org/). The coverage was normalised to the number of 
the genes, thus getting the average sRNAs per gene. Fig. R5 
highlights two very intriguing findings: firstly, the majority of 
AGO2-associated “other RNAs” are transcribed from 
SWI/SNF-bound TSS. For this reason, nuclear AGO2-
associated TSSa RNAs have been named “swiRNAs”. 
Secondly, Fig R5 clearly shows that swiRNAs arise from both 
sense and antisense strands. Even though previous works 
identified TSSa RNAs up to 100 nt in length transcribed from 
sense and antisense strand (Seila et al. 2008; Valen et al., 
2011), the specific size distribution of AGO2-bound “other 
sRNAs” I observe indicates the existence of a novel and 
uncharacterized class of AGO2-bound sRNAs.  
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Fig R5: a. Average per gene coverage of AGO2-associated “other 
sRNAs” around SWI/SNF bound TSS (ENCODE ChIP-seq data). 
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Average per gene coverage is defined as the sum of sRNAs mapping to a 
given position (relative to TSS) divided by number of TSS analysed. Only 
“other sRNAs” lying within clusters of < 50 molecules were considered. b. 
Average per gene coverage of AGO2-associated “other sRNAs” around 
TSS without SWI/SNF binding sites (ENCODE ChIP-seq data). Average 
per gene coverage is defined as the sum of sRNAs mapping to a given 
position (relative to TSS) divided by number of TSS analysed. Only “other 
sRNAs” lying within clusters of < 50 molecules were considered. 
 
 
 
swiRNAs are processed in a Dicer-dependent manner 
In humans, Dicer processes both long dsRNAs and pri-
miRNAs into siRNA duplexes and miRNA duplexes, 
respectively (Zhang et al., 2002; Provost et al., 2002). 
I reasoned that complementary long TSSa RNA pairs might 
form a dsRNA molecule suitable for DICER processing, 
pinpointing long TSSa RNAs as swiRNAs precursors. 
Thus, in order to investigate this hypothesis, I looked at the 3’ 
termini of pairs of swiRNAs lying on opposite strands of the 
same locus. The idea is that I can compute the distance of the 
3’ termini and plot it in function of the frequencies at which I 
observe these distances.  
My results could lead to two different scenarios:  in the first 
case I could observe a heterogeneous distribution of distances, 
because of random chance. In the second case, I could observe 
a sharp peak in correspondence of the most distance between 
the 3’ termini of pairs of swiRNAs lying on opposite strands of 
the same locus, which would be suggestive of an enzymatic 
processing.  As depicted in fig. R6, the final plot indicates a 
clear enrichment for the  2 nt 3’ overhang, which is a specific 
hallmark of DICER processing.  
Starting from this strong suggestion, I decided to shed more 
light on Dicer involvement in swiRNAs processing. 
Therefore, in order to study the effects of loss of DICER on 
swiRNAs processing, we performed an RNA 
Immunoprecipitation and profiled by Next Generation 
Sequencing (NGS) the sRNAs specifically bound to nuclear 
AGO2 in wild type HCT116 human colon cancer cell lines and 
DICERex5 HCT116 cell lines. In HCT 116 DICERex5 cell 
lines, DICER gene exon 5, which encodes for the helicase 
domain, was deleted via homologous recombination (Cummins 
et al., 2006).  
 
 
FIG. R6: swiRNAs display a 2 nt 3' overhang typical of DICER-
processed sRNAs. The length (nt) of 3' overhang for pairs of 
complementary swiRNAs was plotted. Negative values represent a 5' 
overhang. Most pairs display a 2 nt 3' overhang, suggestive of DICER 
processing. 
It is worth mentioning that we have  demonstrated that the 
interaction of AGO2 and SWI/SNF subsists also in the nuclei 
of HCT116 and DICERex5 HCT116 cells, as previously shown 
for HeLa cell lines (Data not shown). As control, a parallel 
immunoprecipitation using isotype matched IgG was 
performed. RNAs extracted from the total nuclear RNA sample 
(Input) and from the IPs samples were subjected to deep-
sequencing. 
The sequencing experiment produced the following amount of 
data:  
• 176.154.736 short reads in HCT116 wt input sample. 
• 161.631.990 short reads in HCT116 wt RIP-Ago2 
sample. 
• 159.612.886 short reads in HCT116 wt RIP IgG wt 
sample. 
• 145.659.010 short reads in HCT116 DICEREX5 input 
sample. 
• 165.007.012 short reads in HCT116 DICEREX5 RIP-
Ago2 sample. 
• 146.507.557 short reads in HCT116 DICEREX5 RIP-
IgG sample. 
 
In order to pre-process the reads and to map them to the human 
genome I used the same bioinformatics pipeline I set-up for the 
AGO2-associated sRNAs observed in HeLa cell lines. 
As shown in the figure R7, the presence of “other sRNAs” is 
confirmed in HCT116 cell lines as well as in  HCT116 
DICEREX5 sub-clone. Furthermore, also the “other sRNAs” 
size distribution profile is very similar to the one observed in 
HeLa cell lines. Intriguingly, we can observe a reduction of 
“other sRNAs” mapping within 1kb of TSS of expressed genes 
in absence of Dicer (FIG. R7-f). 
 FIG R7: a-b. Genomic annotation of sRNA-Seq data in HCT116 and 
HCT116 DICEREx5. The histograms illustrate the sRNA classes identified in 
AGO2- or IgG-IP samples. c-d. Size distribution of AGO2- and IgG-IP 
“other sRNAs” . Number of reads of “other sRNAs” in AGO2- or IgG-IP 
samples and corresponding length (nt) are plotted. e-f. Percentage of “other 
sRNAs” in AGO2- or IgG-IP samples mapping within 1 kb of TSS of 
expressed genes (TSS were defined by mRNA-seq). Only “other sRNAs” 
lying within clusters of < 50 molecules were considered. 
 Therefore, in order to test whether the absence of Dicer could 
affect swiRNAs processing, I computed the coverage of 
swiRNAs around TSS of expressed genes both in HCT116 and 
DICERex5 cell lines. 
Coverage at each position represents the number of swiRNAs 
mapping at the indicated distance from a TSS, normalized by 
the total number of “other sRNAs”. 
Accordingly, I observed a drastic reduction of swiRNAs in 
HCT116 DICEREX5 relative to parental HCT116, which 
confirms that swiRNAs are processed by DICER (Fig R8).  
As a control, I checked for AGO2-bound sRNAs mapping on 
Transcription Termination Sites (TTS) (Valen et al., 2011) and 
observed that they are not affected by DICER depletion (Fig. 
R9).  
Based on to the specific size, the DICER mediated processing 
and the AGO2 association, I can conclude that swiRNAs are a 
novel class of sRNAs distinct from any other class of sRNAs 
mapping near TSS previously described (Seila et al., 2008; 
Valen et al., 2011; Taft et al., 2009). 
 FIG. R8: Dicer depletion affects swiRNAs processing. Coverage of 
swiRNAs in parental HCT116 cell line (upper panel) and in HCT116 
DICEREx5 cell line (lower panel) (blue: sense strand; red: antisense strand). 
Coverage at each position represents the number of swiRNAs mapping at 
the indicated distance from a TSS, normalized by the total number of “other 
sRNAs”. Only “other sRNAs” lying within clusters of < 50 molecules were 
considered. 
 
FIG. R9:AGO2-associated Transcription Termination Site associated 
(TTSa) RNA are not processed in a DICER-dependent manner. 
Coverage of swiRNAs in parental HCT116 cell line (panel a.) and in 
HCT116 DICEREx5 cell line (panel b.) (blue: sense strand; red: antisense 
strand). Coverage at each position represents the number of “other” RNAs 
mapping at the indicated distance from a TTS, normalized by the total 
number of “other sRNAs”. Only “other sRNAs” lying within clusters of < 
50 molecules were considered.  
Analysis of mRNA expression level changes upon Ago2 
knock-down 
The identification of a new macromolecular complex including 
AGO2, core components of SWI/SNF and swiRNAs suggests 
the involvement of AGO2 in SWI/SNF-mediated nucleosome 
positioning. As nucleosome positioning affects DNA 
accessibility and mRNA transcription levels, I wanted to test 
whether any transcriptomic changes could be induced upon 
AGO2 depletion. Therefore, we knocked down AGO2 in 
HeLaS3 cells and looked at mRNA expression profiles in 
control and AGO2 Knock-Down HeLaS3 cells through NGS 
experiments conducted in two independent biological replicas. 
As shown in Fig. R10, down-regulation of AGO2 protein was 
verified by western blot analysis. 
 
 
 Fig. R10: Down-regulation of   
AGO2 protein in HeLaS3 cells.  
Cells were transfected with siCTRL 
or siAGO2. Down-regulation of 
AGO2 protein was verified by 
western blot. GAPDH was used as 
loading control.  
Then, total mRNA was extracted in the three samples 
(untreated, siCtrl and siAgo2) and sequenced on an Illumina 
HiSeq2000 machine in paired-end mode. Paired-end 
sequencing represents a simple modification to the standard 
single-read DNA library preparation and facilitates reading 
both the forward and reverse template strands of each cluster. 
In addition to sequence information, both reads contain long 
range positional information, allowing for highly precise 
alignment of reads. The paired-end run set up for my 
experiment produced 2 × 100 bp reads. 
The amount of my sequencing data is as follows (sum of two 
biological replicates): 
• 37.403.780 paired-end reads input sample. 
• 37.059.506 paired-end reads siCtrl sample. 
• 44.727.903 paired-end reads siAgo2 sample. 
Therefore, I performed the routine quality check with Fastqc 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). 
If a sequencer is unable to make a base call with sufficient 
confidence then it will normally substitute an N rather than a 
conventional base call. It's not unusual to see a very low 
proportion of N appearing in a sequence, especially close to the 
end of a sequence. Indeed I noticed that also my reads 
presented an increase of the N strarting from 87th position on. 
The presence of the N during the mapping step can strongly 
condition the percentage of reads that correctly align to 
genome, because the more mismatches I have during the 
mapping the less percentages of reads I can align to the 
reference genome. In order to preserve my depth of 
sequencing, I  decided to trim my reads from the 87th position 
on with the bioinformatics tool Trimmomatic (Lohse et al., 
2012; http://www.usadellab.org/cms/?page=trimmomatic ). 
 
Fig R11: N % across all bases. This module plots out the percentage of 
base calls at each position for which an N was called. Here it is represented 
the Input sample. The other samples show a very similar N% distribution. 
 
Afterwords, reads were mapped with the bioinformatics tool 
TopHat 2.0.9
 
(Kim D. et al., 2013). TopHat is a fast splice 
junction mapper for long RNA-Seq reads. By first mapping 
RNA-Seq reads to the human genome, TopHat identifies 
potential exons, since many RNA-Seq reads will contiguously 
align to the genome. Using this initial mapping information, 
TopHat builds a database of possible splice junctions and then 
maps the reads against these junctions to confirm them. Short 
read sequencing machines can currently produce reads 100bp 
or longer but many exons are shorter than this so they would be 
missed in the initial mapping. TopHat solves this problem 
mainly by splitting all input reads into smaller segments which 
are then mapped independently. The segment alignments are 
put back together in a final step of the program to produce the 
end-to-end read alignments. TopHat generates its database of 
possible splice junctions from two sources of evidence. The 
first and strongest source of evidence for a splice junction is 
when two segments from the same read (for reads of at least 
45bp) are mapped at a certain distance on the same genomic 
sequence or when an internal segment fails to map - again 
suggesting that such reads are spanning multiple exons. With 
this approach, "GT-AG", "GC-AG" and "AT-AC" introns will 
be found ab initio. The second source is pairings of "coverage 
islands", which are distinct regions of piled up reads in the 
initial mapping. Neighbouring islands are often spliced 
together in the transcriptome, so TopHat looks for ways to join 
these with an intron 
(http://tophat.cbcb.umd.edu/manual.shtml). The mapping rate 
for my NGS data was very high, indeed 100% of my reads very 
properly aligned on the human genome. After the reads were 
mapped on the genome, it was necessary a step of transcripts 
assembly. Cufflinks (v 2.1.1) (Trapnell et al., 2013) constructs 
a parsimonious set of transcripts that "explains" the reads 
observed in an RNA-Seq experiment. I therefore ended up with 
a list of genes expressed in HeLaS3 cells under my growth 
conditions. Differential gene expression analysis was exerted in 
parallel with two different softwares: Cuffdiff (Trapnell et al., 
2013; http://cufflinks.cbcb.umd.edu/howitworks.html#difftest) 
and DESeq, an R package released by BioConductor (Anders 
and Huber, 2010). Accordingly, the results obtained from these 
two algorithms have shown to be highly comparable. In detail, 
DESeq steps as follows. As a first processing step, I needed to 
estimate the effective library size. This step is sometimes also 
called normalisation, even though there is no relation to 
normality or a normal distribution. The effective library size 
information is called the size factors vector, since DESeq 
package only needs to know the relative library sizes. If the 
counts of non-differentially expressed genes in one sample are, 
on average, twice as high as in another (e.g. because the library 
was sequenced twice as deeply), the size factor for the first 
sample should be twice that of the other sample. Having 
estimated the dispersion for each gene, it is straight-forward to 
look for differentially expressed genes. To contrast two 
conditions, e.g., to see whether there is differential expression 
between conditions “siCtrl” and “siAGO2”, I have performed a 
binomial test in order to compute p-values associated to the 
log2 fold changes computed. As shown in Fig. R12 
(differentially expressed genes are coloured in red) mRNA 
expression profile analysis did not highlight significant 
changes in the expression level of mRNAs transcribed from 
Ago2 knock-down sample compared to the control one.  
 Fig. R12: The function plotMA, from the R package DESeq, plots the log2 
fold changes against the mean normalised counts, colouring in red those 
genes that are significant at 10% FDR. 
 
It is also instructive to look at the histogram of p-values 
(Figure R13). The enrichment of low p-values would stem 
from the differentially expressed genes, while those not 
differentially expressed are spread uniformly over the range 
from zero to one (except for the p values from genes with very 
low counts, which take discrete values and so give rise to high 
counts for some bins at the right). As shown in the figure there 
is no enrichment for low p-values, which means that no 
significant difference is observed in the transcriptome upon 
Ago2 knock-down. This prompted me to think that Ago2 and 
SWI/SNF interaction might exert some other kind of role in the 
cell. 
 
Fig R13: Histogram of p-values resulted from the call to nbinomtest() 
function from DESeq R package. The lack of enrichment for low p-values 
in this plot indicates that there are no significant differences in the 
transcriptional levels of the two compared samples. 
Analysis of nucleosome occupancy changes 
upon Ago2 knock-down 
 
Therefore, the next step of my PhD work was to assess whether 
nucleosome positioning underwent any changes upon AGO2 
Knock-Down.  
The locations and occupancies of nucleosomes can be assayed 
through the use of enzymatic digestion with micrococcal 
nuclease (MNase), an endo-exo nuclease that preferentially 
digests naked DNA and the DNA in linkers between 
nucleosomes, thus enriching for nucleosome-associated DNA. 
To determine nucleosome organization genome-wide, DNA 
fragments, recovered following MNase digestion, were 
sequenced using high-throughput sequencing technologies 
(MNase-seq) both in control and AGO2 Knock-down cells. 
Paired End sequencing of MNase-digested fragments gave rise 
to the following amount of data: 
 
• 592.534.546 paired-end reads in Ago2 Knock-down 
cells. 
• 711.051.028 paired-end reads in control cells.  
Sequence quality was assessed using FastQc v 0.10.1 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/). 
Paired End reads were then aligned to the human genome using 
Bowtie v 0.12.7
 
(Langmead et al., 2009) allowing at the most 1 
mismatch in the first 30 nts of the read.  
Paired-end sequencing facilitates reading both the forward and 
reverse template strands of each cluster. For a pair to be 
"properly paired" it needs to have both reads mapped to the 
same sequence within a given distance. In my analysis, only 
those reads flagged by Bowtie as “Properly paired” reads were 
further analysed, in order to detect with the maximum precision 
the position of each nucleosome.  
After the mapping step, I checked for the size distribution of 
the fragments.  
As expected, I observed a major peak at 147 and a minor peak 
at  128 nt. Indeed, MNase digestion is known to produce 
fragments of variable size; however shorter fragments (< 100 
nt) are likely to represent the DNA footprint of transcription 
factors, polymerases and other DNA binding proteins. The 
DNA footprint of a nucleosome is expected to be about 146 nt 
long. However, it is known that at low efficiency MNase may 
occasionally nick the 146 nt long nucleosomal DNA at about 
10 nt (one DNA helix turn) into the nucleosome at each end, 
giving rise to a small satellite population of 127 nt fragments 
which do represent nucleosomes. DNA fragments longer than 
200 nt are unlikely to represent bona fide nucleosome 
footprints. We therefore selected Paired End reads with a size 
between 100 and 200 nt.  
As shown in Fig.R14, the size distribution of DNA fragments 
is strikingly similar in the two samples, ruling out the 
possibility of a bias due to unequal digestion and thus allowing 
a proper comparison between the two experimental conditions.  
 
  
 
 
 
 
 
 
 
 
Fig.R14: Distribution of fragment length is remarkably similar in 
siCTRL- or siAGO2-treated HeLaS3 cells. This indicates a comparable 
digestion efficiency for the two samples. Over-digestion of a sample 
compared to the other would have resulted in a higher 128 nt peak and a 
lower 147 nt peak. Y-axis: fraction of fragments. X-axis: fragment length 
(green line: AGO2 Knock-Down HeLaS3 cells; black line: ctrl siRNA 
HeLaS3 cells).  
 
 
After the mapping step, I used a bioinformatics tool, Danpos 
(Chen et al., 2013), in order to carry on comparative analysis of 
nucleosome physical organization at single-nucleotide 
resolution.  
The physical organization of nucleosomes can be described as 
an array of nucleosome units across the genome. 
In different cells, the exact positions of the nucleosomes within 
each unit may deviate more or less while centring around a 
most preferred position. This deviation of nucleosome 
positions within each unit in a cell population is referred to as 
fuzziness. Thus, each nucleosome can be described by a most 
preferred position (hereafter referred to as nucleosome 
position) and its fuzziness, along with an occupancy value 
referring to the frequency with which the unit is occupied in a 
cell population (Kaplan et al. 2010; Pugh 2010). 
Therefore, starting from reads that have been mapped to the 
reference genome, I have executed a preliminary data 
processing with Danpos. Firstly, the program removes clonal 
reads with identical sequences resulting from possible over-
amplification during sample preparation. The clonal reads can 
be determined based on their extremely high coverage relative 
to the mean coverage across the genome using a Poisson P-
value cut-off. Then, nucleosome occupancy was calculated as 
the count of adjusted reads covering each base pair in the 
genome. After the pre-processing step, Danpos used a quantile 
normalization option in order to make the occupancy levels 
comparable in the two samples. Therefore, a Poisson test was 
applied to the nucleosome differential signals computed, in 
order to evaluate the statistical significance of the results. 
Then, a peak calling was performed on the single-nucleotide-
resolution differential signal to identify differential peaks, thus 
classifying them into three categories including nucleosome 
position shifts, fuzziness changes, and occupancy changes. 
Unfortunately, I did not observe any statistically significant 
changes between Ago2 knock-down and control sample for the 
required P-value cut-off of 1 × 10−5 (or a false discovery rate  
<0.01). The same results were obtained using another 
nucleosome calling algorithm, nucleR (Flores and Orozco, 
2011), in defining nucleosome position, occupancy, and 
fuzziness changes. I hypothesized that this weak statistical 
significance could be suggestive of the fact that most of the 
nucleosomes did not undergo differential positioning upon 
Ago2 knock-down or that each change, taken individually, was 
not significant. Indeed, we have to keep in mind that FDR 
represents the adjusted p-value computed for multiple testing, 
that is for all the nucleosomes I find all over the genome. This 
method, on one hand reduces the false positive rate observation 
but, on the other hand, could mask actually significant signals 
arising from a little subclass of nucleosomes which, on the 
contrary, undergo differential occupancy changes. 
Therefore, I decided to change my strategy and focused my 
attention only on the average nucleosome occupancy profiles 
around all TSS of expressed genes in the two samples. Since 
AGO2 is associated with swiRNAs, mapping nearby TSS and 
SWI/SNF has been reported to bind TSS of expressed genes 
(Tolstorukov et al., 2013),  I used the TSS coordinates of the 
21.265 genes expressed in HeLaS3 derived on my previous 
RNA-seq analysis of mRNAs under our growth conditions (see 
above paragraph). Nucleosome Occupancy was computed 
using coverageBed (from BedTools package, Quinlan et al., 
2010) and a custom perl script to determine cumulative 
occupancy over multiple loci.  
Occupancy was normalized by the total number of sequenced 
nucleotides in each library taking into account Properly Paired 
read pairs with a length between 100 and 200. Consistently 
with  previous results (Schones et al.,2008; Jiang et al., 2009; 
Hartley et al., 2009), I observed in both samples a nucleosome-
free region located immediately upstream the TSS, flanked by 
two well-positioned nucleosomes, referred to as -1 and +1 
nucleosome. By restricting my analysis only on regions 
corresponding to nucleosome +1  relative to TSS, I found a 
mild (1.98%) but highly significant (P-value = 1.5×10-15, 
paired t-test; see experimental procedures for the computing of 
the p-value) decrease in the average occupancy at nucleosome 
+1 in AGO2 Knock-Down cells (data not shown). Afterwards, 
I restricted my analysis only on TSS overlapped by swiRNAs.  
Therefore, I have created several groups of genes selected 
based on the minimum number of swiRNAs mapping within ± 
150 nt of TSS and repeated the computation for each group. 
Nucleosome +1 occupancy was defined as the sum of the 
coverage at each nucleotide position in the interval between nt 
+100 and nt +300 relative to TSS for each group of genes.  
A paired t-test was performed to compute P-value of the 
difference observed between average coverage at nucleosome 
+1 in AGO2 knock-down and Ctrl siRNA cells.  
For each group of n genes (whose TSS were overlapped by at 
least m swiRNAs) 10000 random permutations were performed 
to estimate FDR. In each permutation, n random genes were 
chosen (among the 21265 genes expressed in HeLaS3 cells) 
and the P-value was computed comparing occupancy at 
nucleosome +1 with the same procedure outlined above for the 
real case. All real cases with a P-value < 0.01 were tested, and 
FDR was always estimated to be < 0.01.   
Intriguingly, AGO2-dependent reduction in nucleosome 
occupancy positively correlated with the number of swiRNAs 
mapping within ± 150 nt from TSS (Fig R15-a). On the 
contrary, there was no correlation between nucleosome +1 
occupancy changes and IgG-IP nor AGO1-IP sRNAs 
overlapping each TSS. These data are in agreement with the 
fact that AGO1 does not interact with SWI/SNF (see 
preliminary data) and indicate that the observed phenotype is 
not due to a differential recovery of nucleosomes mapping near 
the more expressed genes (Fig. R15-b). 
a. 
 
 
 
 
  
b. 
 
 
 
 
 
 
 
Fig.R15: a. The occupancy at the nucleosome +1 is reduced in AGO2 
Knock Down cells and depends on swiRNAs mapping between -150 
/+150 nt relative to TSS. Chromatin from siCtrl- or siAGO2-treated 
HeLaS3 cells was digested by MNase and recovered DNA fragments were 
sequenced. Bars height represents percent reduction of nucleosome 
occupancy (siAGO2 vs siCTRL) at TSS (+/- 150 nt) overlapped by at least 
the indicated number of swiRNAs (green), IgG-IP “other sRNAs” (black) 
and AGO1-associated “other sRNAs” (purple).  Differences depicted with 
green bars (AGO2 IPed sRNAs) are highly significant (P value < 0.01, 
paired t-test). b. The number of AGO2-associated swiRNAs overlapping 
each TSS does  not correlate with gene expression level. Bar height 
represents average gene expression in untreated HeLaS3 cells at TSS (+/- 
150 nt) overlapped by at least the indicated number of swiRNAs (green), 
IgG IP “other sRNAs” (black) and AGO1 associated “other sRNAs” 
(purple). Expression values in FPKM summarized at gene level and 
obtained from Cuffdiff software were used to compute average expression 
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values reported in this bar-plot. sRNAs coverage was computed using TSS 
coordinates restricted to the 21265 loci expressed in HeLaS3 cells under our 
growth conditions. No further filtering based on the level of expression of 
mRNAs was applied.  
 
As shown in Fig R16, occupancy at nucleosome +1 
downstream of TSS for the subclass of genes with at least 30 
swiRNAs lying nearby their TSS  was strongly (14%, paired t-
test P-value = 0.0001687, FDR < 0.01) affected by AGO2 
depletion. This phenotype resembles the one observed in 
murine cells where core components of SWI/SNF have been 
genetically ablated (Tolstorukov et al., 2013).  
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Fig.R16. Nucleosome occupancy profile for siCTRL and siAGO2 cells was 
plotted for TSS of HeLaS3 cells with at least 30 swiRNAs mapping 
between nt -150 / +150 relative to TSS (siCTRL, black line; siAGO2, green 
line).  
 
 
Overall, these results strongly support the idea that the newly 
identified AGO2-associated sRNAs (swiRNAs) are key players 
in nucleosome +1 positioning.  
 
 
 
 
EXPERIMENTAL PROCEDURES 
Cell culture and transfection. HeLa S3, Jurkat and HEK293T 
cells were grown in DMEM medium supplemented with 10% 
(v/v) fetal bovine serum, 2mM L-Glutamine and Penicillin-
Streptomycin. HCT 116 WT and DICEREx5 cells1 were grown 
in McCoy’s 5A medium supplemented with 10% (v/v) fetal 
bovine serum, 2mM L-Glutamine and Penicillin-Streptomycin. 
Transfections were done with 10 nM siRNAs (siAGO2: a pool 
containing the following siRNAs 
GCAGGACAAAGAUGUAUAA[dT][dT]2 and 
CGUCCGUGAAUUUGGAAUCAU[dT][dT] (Sigma); 
siCTRL: AGCUUCAUAAGGCGCAUGC[dT][dT]) for 4 days 
using INTERFERin® as transfecting agent according to the 
manufacturer's instructions (Polyplus Transfection).  
Western blot. Western blot analyses were carried out 
according to standard procedures using the following 
antibodies: anti-AGO2 (11A9, Ascenion)4, anti-GAPDH 
(14C10, Cell Signaling technology), anti-Histone Antibody, H1 
+ core proteins (F152.C25.WJJ, Millipore), anti-β-TubulinI 
(SAP.4G5, SIGMA), goat-anti mouse and anti-rabbit IgG-HRP 
conjugated (Bio-Rad), anti-rat IgG-HRP conjugated (Jackson). 
Preparation of total, nuclear and cytosolic cell extract. For 
total cell extract, cells were washed twice with cold PBS, 
scraped off the culture plates with PBS and then lysed in 
appropriates volumes (20×106 cells/ml) of IP-buffer (150 mM 
KCl; 25 mM NaCl; 2 mM EDTA; 0.5% NP40; 0.5 mM DTT; 
protease inhibitor (Sigma)) for 20 min on ice. Lysate was 
clarified by centrifugation at 16,000 g for 10 min at 4°C. 
Cytosolic and nuclear extracts were prepared as following: 
cells were resuspended, firstly, in two volumes of ice-cold 
buffer I (0.3 M sucrose in 60 mM KCl; 15 mM NaCl; 5 mM 
MgCl2; 0.1 mM EGTA; 15 mM Tris-HCl pH 7.5; 0.5 mM 
DTT; protease inhibitors), then added other two volumes of 
ice-cold Buffer II (0.3 M sucrose in 60 mM KCl; 15 mM NaCl; 
5 mM MgCl2; 0.1 mM EGTA; 15 mM Tris-HCl pH 7.5; 0.5 
mM DTT, 0.4% NP-40, protease inhibitors) in order to obtain 
25×106 cells per ml, and placed on ice for 10 min. Afterwards, 
cell lysate was layered on 24 ml of a sucrose cushion (1.2 M 
sucrose in 60 mM KCl; 15 mM NaCl; 5 mM MgCl2; 0.1 mM 
EGTA; 15 mM Tris-HCl pH 7.5; 0.5 mM DTT) and 
centrifuged in a pre-chilled swing-out rotor at 10,000 g for 20 
minutes at 4°C. The upper phase containing the cytoplasmic 
fraction was collect and the pellet containing cell nuclei was 
lysed in IP-buffer (20×106 cells/ml) and clarified. Fractionation 
efficiency was evaluated by western blotting analysis. H1 and 
GAPDH proteins were used as controls for the nuclear and 
cytosolic fraction, respectively. 
Immunoprecipitation (IP) and co-immunoprecipitation. 
Antibodies (anti-AGO1 (4B8, Ascenion); anti-AGO2 (11A9, 
Ascenion) and isotype-matched IgG (as mock IP) were coupled 
to Protein-G-sepharose beads (Sigma) for 2 hr at 4°C and 
washed once in IP buffer and twice in IP-wash buffer (50 mM 
Tris-HCl, pH 7.5; 300 mM NaCl; 5 mM MgCl2; and 0.05% 
Nonidet P-40). Whole-cell lysate (40×106 - 80×106 cells) or 
nuclear fraction (60×106 - 160×106 cells) were incubated 
overnight at 4°C under constant rotation with antibodies pre-
coupled beads. An aliquot of total extracts was taken out as 
Input. IP samples were washed once with IP-buffer for 5 min 
and three times with IP-wash buffer. Proteins were eluted from 
beads by boiling for 5 min in SDS-PAGE sample buffer 
(Sigma). Immunoprecipitation efficiency and co-
immunoprecipitating proteins were analyzed by western 
blotting.  
Nuclear RNA-Immunoprecipitation (RIP). Nuclei of HeLa 
S3, Jurkat, HCT116 WT and DICEREx5 cell lines were lysed in 
IP-buffer supplemented with RNasin (Promega). Nuclear 
lysates were clarified and pre-cleared in the presence of Protein 
G-sepharose beads for 2 hr 4°C under constant rotation and 
then filtered through a 0.45 μm filter. Lysate aliquots were 
taken out as Input for RNA and protein isolation. Antibodies 
and isotype-matched IgG (mock IP) were coupled to Protein G-
sepharose beads for 2 h at 4°C in IP-buffer containing 1 mg/ml 
heparin (Sigma). The pre-cleared lysate corresponding to 
150×106 nuclei for AGO2-RIP or 350×106 cells for AGO1-RIP 
were incubated with antibody-coupled beads overnight at 4°C 
under constant rotation. IP samples were washed once with IP-
buffer for 5 min at 4°C, and three times with IP-wash buffer at 
4°C. An aliquot was taken out for western blot. For RNA 
isolation, Input and IP samples, were DNAseI- and Proteinase 
K (Roche)-treated. Total RNA and co-precipitated RNA were 
extracted by phenol:chloroform:isopropyl alcohol and 
precipitated in ethanol.  
Isolation of nucleosomal DNA by Micrococcal Nuclease 
(MNase) digestion. Digestion of chromatin from untreated, 
siCTRL- or siAGO2-treated HeLa S3 cells (2 × 106) was 
performed with 50U of MNase (New England Biolabs) in 
300uL of Permeabilization buffer (15mM Tris-HCl pH 7.4, 
300mM sucrose, 60 mM KCl, 15 mM NaCl, 4mM CaCl2, 
0.5mM EGTA, 0.2% NP-40, 0.5mM β-mercaptoethanol) for 20 
min at 37°C. The reaction was stopped by addition of 300uL of 
Stop Buffer (50mM  Tris-HCl pH 8, 20mM EDTA, 1% SDS) 
for 2 min on ice. RNA was degraded with 75 µg RNAse A for 
1 h at 37°C and cellular proteins digested with 30 µg Proteinase 
K for 1h at 55°C. Nucleosomal DNA was purified by 
phenol:chloroform extraction and precipitated in ethanol. DNA 
size was verified by separation on 2% agarose gel and by 
Agilent 2100 Bioanalyser (Agilent Technologies). DNA was 
mostly digested as 1 n nucleosomal DNA.  
Library construction and sequencing. Library construction 
and sequencing was performed by the Institute of Applied 
Genomics (IGA) Technology Services (Italy). Samples were 
sequenced on an Illumina HiSeq2000. 
mRNA Sequencing Analysis.Reads were aligned using 
TopHat 2.0.9
 
and transcripts were assembled with cufflinks (v 
2.1.1) with the following options: 
-g iGenome_hg19_genes.gtf  -M mask_hg19.gtf -b hg19.fa  
where:  iGenome_hg19_genes.gtf contains annotation of 
known transcripts (iGenome UCSC hg19). mask_hg19.gtf 
contains genomic coordinates of annotated rRNAs and 
tRNAshg19.fa is the fasta file containing sequence of the 
human genome hg19.transcripts were merged using 
cuffcompare (2.1.1)
 
using the -R option, to exclude from final 
report any transcript which was not overlapped by any 
fragment in our RNA-seq dataset. I therefore ended up with a 
list of genes expressed in HeLaS3 cells under our growth 
conditions. All analyses conducted using TSS coordinates 
(sRNAs coverage, nucleosome occupancy) were restricted to 
the 21265 loci expressed in HeLaS3 cells under our growth 
conditions. No further filtering based on the level of expression 
of mRNAs was applied. Expression values in FPKM 
summarized at gene level were used to compute average 
expression values reported in Supplementary Figure 10.  
• DESeq analysis: 
##count table creation: 
 
samtools sort -n accepted_hits.bam 
accepted_hits.sorted 
samtools view accepted_hits.sorted.bam | grep -v 
"chrM" > dup_rem.sam 
rm accepted_hits.sorted.bam 
htseq-count -m intersection-nonempty dup_rem.sam 
bowtie0.12.7/indexes/transcriptome_data/iGenome_
hg19_genes.gff > sample1.counts.tsv 
rm dup_rem.sam 
R 
library("DESeq") 
data <- data.frame(c("input.r1", "siCtrl.r1", 
"siAgo.r1" ,"input.r2", "siCtrl.r2", 
"siAgo.r2"), 
c("sample1.counts.tsv","sample2.counts.tsv", 
"sample3.counts.tsv" 
,"sample4.counts.tsv","sample5.counts.tsv", 
"sample6.counts.tsv"), c("untreated", "siCtrl", 
"siAgo", "untreated", "siCtrl", "siAgo" )) 
colnames(data) <- c("sample", "name", 
"condition") 
cds <- 
newCountDataSetFromHTSeqCount(sampleTable=data, 
directory=".") 
cds <- estimateSizeFactors( cds ) 
sizeFactors(cds) 
norm.cds <- counts( cds, normalized=TRUE )  
cds = estimateDispersions( cds ) 
plotDispEsts(cds) 
siAgo.vs.siCtrl <- nbinomTest(cds, "siAgo", 
"siCtrl") 
plotMA(siAgo.vs.siCtrl) 
hist(siAgo.vs.siCtrl$pval, breaks=100, 
col="skyblue", border="slateblue", main="") 
siAgo.vs.input <- nbinomTest(cds, "siAgo", 
"untreated") 
plotMA(siAgo.vs.input)  
siAgo.vs.siCtrl.Sig = 
siAgo.vs.siCtrl[(siAgo.vs.siCtrl$padj < 0.1), ] 
sum(siAgo.vs.siCtrl$padj<0.1, na.rm=T) 
#[1] 13 
#sum(siAgo.vs.input$padj < 0.1, na.rm=T) 
[1] 2 
 
Small RNA Sequencing analysis. 
• Reads quality was checked using FastqC v0.10.1 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 
fastqc Sample$i.fastq.gz 
• Sequences were quality trimmed (H.Li: 
https://github.com/lh3/seqtk) and adapters were 
removed using cutadapt v 1.0
 
 (Martin, M. , 2011) . 
seqtk trimfq <(gunzip -c Sample$i.fastq.gz) 
| cutadapt  -m18 -a TGGAATTCTCGGG - | gzip > 
$TDIR/trimmed_adapt_rem.gz 
• Sequences were iteratively aligned to different databases 
to identify RNAs which did not belong to any known 
AGO2 associated class of RNA. After each alignment 
round reads with no alignments were used in the next step. 
Alignements were performed using Bowtie 0.12.7
  
 
(Langmead et al., 2009)with the following options: -n 0 -l 
18 (requiring no mismatches in the first 18 nt of the reads). 
RNAs mapping to a single locus on hg19 at this step were 
called “other sRNAs” and further analyzed.  “other 
sRNAs” alignements were converted into BED format for 
both AGO2 sample and IgG control (AGO2_sRNAs.BED 
and IgG_sRNAs.BED) and further analysed using the 
bedtools package as follows: “other sRNAs” were divided 
in clusters (requiring same strandness) using mergeBed 
program (mergeBed -s); most clusters consisted of less 
than 50 sRNAs, while a few hundred clusters consisted of 
tens of thounsands of identical reads. These high-copy 
clusters likely represent novel miRNAs or PCR artifacts. 
We therefore decided to focus our attention on sRNAs in 
low copy clusters (< 50 sRNAs) and removed from 
AGO2_sRNAs.BED and IgG_sRNAs.BED reads lying 
into High-copy clusters (> 50 reads). 
bowtie -p 4 -t -n 0 -l 18 -q --al 
$TDIR/aligned_to_miRNA --un 
$TDIR/unaligned_to_miRNA 
indexes_for_sRNA_analysis/mirbase_20 <(zcat 
$TDIR/trimmed_adapt_rem.gz) > 
$TDIR/alignements_to_miRNA 2> 
$TDIR/logs/miR_bowtie_log 
tar -pczf $TDIR/alignements.to.miRNA.tar.gz 
$TDIR/alignements_to_miRNA 
rm $TDIR/alignements_to_miRNA 
tar -pczf $TDIR/aligned_to_miRNA.tar.gz 
$TDIR/aligned_to_miRNA 
rm $TDIR/aligned_to_miRNA 
bowtie -p 4 -t -n 0 -l 18 -q --al 
$TDIR/aligned_to_tRNA_rRNA --un 
$TDIR/unaligned_to_tRNA_rRNA 
indexes_for_sRNA_analysis/hsa_rRNA_tRNA 
$TDIR/unaligned_to_miRNA > 
$TDIR/alignements_to_tRNA_rRNA 2> 
$TDIR/logs/tRNA_rRNA_bowtie_log 
tar -pczf $TDIR/unaligned_to_miRNA.tar.gz 
$TDIR/unaligned_to_miRNA 
rm $TDIR/unaligned_to_miRNA 
tar -pczf $TDIR/aligned_to_tRNA_rRNA.tar.gz 
$TDIR/aligned_to_tRNA_rRNA 
rm $TDIR/aligned_to_tRNA_rRNA 
tar -pczf $TDIR/alignements_to_tRNA_rRNA.tar.gz 
$TDIR/alignements_to_tRNA_rRNA 
rm $TDIR/alignements_to_tRNA_rRNA 
bowtie -p 4 -t -n 0 -l 18 -q --al 
$TDIR/aligned_to_Rfam_manually_cured --un 
$TDIR/unaligned_to_Rfam 
indexes_for_sRNA_analysis/Rfam_hsa_manually_cure
d $TDIR/unaligned_to_tRNA_rRNA > 
$TDIR/alignements_to_Rfam_manually_cured 2> 
$TDIR/logs/Rfam_manually_cured_bowtie_log 
tar -pczf $TDIR/unaligned_to_tRNA_rRNA.tar.gz 
$TDIR/unaligned_to_tRNA_rRNA 
rm $TDIR/unaligned_to_tRNA_rRNA 
bowtie -p 4 -t -n 0 -l 18 -q -m 1 --al 
$TDIR/aligned_to_hg19 --max $TDIR/Mum_to_hg19 --
un $TDIR/unaligned_to_hg19 
~/miei_eseguibili/bowtie-0.12.7/indexes/hg19 
$TDIR/unaligned_to_Rfam > $TDIR/sRNAs 2> 
$TDIR/logs/hg19_bowtie_log 
tar -pczf $TDIR/unaligned_to_Rfam.tar.gz 
$TDIR/unaligned_to_Rfam 
rm $TDIR/unaligned_to_Rfam 
tar -pczf $TDIR/aligned_to_hg19.tar.gz 
$TDIR/aligned_to_hg19 
rm $TDIR/aligned_to_hg19 
tar -pczf $TDIR/unaligned_to_hg19.tar.gz 
$TDIR/unaligned_to_hg19 
rm $TDIR/unaligned_to_hg19 
awk 'BEGIN {FS= "\t"; OFS="\t"} {print $3, $4, 
$4+length($5), $1, 1,$2}' $TDIR/sRNAs > 
$TDIR/sRNAs.bed 
awk '{print $3-$2}' $TDIR/sRNAs.bed | sort -n | 
uniq -c | sed 's/^[ ]*//' > $TDIR/sRNA_length 
mergeBed -s -i $TDIR/sRNAs.bed -n > 
$TDIR/clusters.bed 
awk -v n=$4 -v OFS='\t' '{if ($4 <= 50) print 
$1,$2,$3,"name",$4,$5 }' $TDIR/clusters.bed > 
$TDIR/LC_clusters.bed 
awk -v n=$4 -v OFS='\t' '{if ($4 > 51) print 
$1,$2,$3,"name",$4,$5 }' $TDIR/clusters.bed > 
$TDIR/HC_clusters.bed 
intersectBed -a $TDIR/sRNAs.bed -b 
$TDIR/LC_clusters.bed -s -u -wa > 
$TDIR/sRNAs_in_LC.bed 
intersectBed -a $TDIR/sRNAs.bed -b 
$TDIR/HC_clusters.bed -s -u -wa > 
$TDIR/sRNAs_in_HC.bed 
awk '{print $3-$2}' $TDIR/sRNAs_in_LC.bed | sort 
-n | uniq -c | sed 's/^[ ]*//' > 
$TDIR/sRNA_in_LC_length 
awk '{print $3-$2}' $TDIR/sRNAs_in_HC.bed | sort 
-n | uniq -c | sed 's/^[ ]*//' > 
$TDIR/sRNA_in_HC_length 
done 
 
• Length distribution computing: 
 
samtools view *.bam | cut -f10 | perl -e 
'my @c=(0) x 51; while ( $_ =<STDIN> ) 
{chomp; $c[length ($_)-1]=$c[length ($_)-
1]+1;} $OUT=join("\n",@c); print 
"$OUT\n";' | sed = | sed 'N;s/\n/\t/g' > 
length.distr.sample* 
 
• To compute the overlap between sRNAs and other 
genomic features we calculated the fraction of “other 
sRNAs” with at least a nt overlap with the feature of 
interest (e.g. CpG islands) using intersectBed tool. 
Exact binomial test was used to compute P-values, 
using the frequency of “other sRNAs” overlapping a 
given feature as the expected frequency (null 
hypothesis). coverageBed tool was used with the -s and 
-S options to compute coverage of sense “other sRNAs”  
and antisense “other sRNAs” around each TSS. The 
TSS coordinates were obtained by analysis of HeLaS3 
mRNA-seq (see above). For analysis of HCT116 and 
HCT116 DICER Ex5 cells TSS and TTS of human genes 
were retrieved from ENSEMBL human gene annotation 
(version 69)17. Occupancy profiles around each TSS 
were piled up and normalized by the total number of 
“other sRNAs” to obtain the cumulative profile (TTS). 
 coverageBed -s -a sRNAs_in_LC.bed -b 
1000_nt_around_ENSG_TSS.bed -d | cut -f 6,7,8 
| perl parse_and_join_coverage.pl > 
coverage.LC.Sample$.sense.1000nt.arnd_tss 
coverageBed -S -a sRNAs_in_LC.bed -b 
1000_nt_around_ENSG_TSS.bed -d | cut -f 6,7,8 
| perl parse_and_join_coverage.pl > 
coverage.LC.Sample$.antisense.1000nt.arnd_tss 
(where parse_and_join_coverage.pl is a custom perl 
script). 
• Computing of the norm.value: 
             wc -l sRNAs_in_LC.bed  
 
• Graphics production: 
 R 
Sample$.sense <-
read.table("coverage.LC.Sample$.sense.1000nt.arn
d_tss")/norm.value 
Sample$.antisenso <- 
read.table("coverage.LC.Sample$.antisense.1000nt
.arnd_tss")/norm.value 
X11(width=16,height=8) 
#par(mar=c(8,8,8,8)) 
par(cex = 1.5, mar =c(5,5,5,2)) 
#png (filename="TSSrna_density(Sample$).png" , 
width= 2000 , height= 1000) 
plot(Sample$.senso[,1], col="blue", 
type="h",xaxt="n", xlab="Distance from TSS 
(nt)", ylab="Average TSSRNA\n coverage per 
gene", main="Coverage of TSSa RNAs associated 
with AGO2 in Sample$", ylim=c(-0.004,0.011)) 
abline(v=1000, lty=2, lwd=0.5) 
lines(Sample$.antisenso[,1], col="red", 
type="h") 
axis(1, at = c(0,500,1000,1500,2000), labels = 
c("-1000","-500",1,500,1000), las=1); 
legend(0,0.009, legend = c("TSSRNA (sense)", 
"TSSRNA (antisense)"), col = c("blue","red"), 
lty = 2, lwd = 10); 
savePlot(filename = 
"Immagini/TSSrna_density(Sample$).tiff", type = 
c("tiff"), device = dev.cur()) 
 
 
dev.off() 
 • Nuclear AGO1 associated sRNAs were analysed using 
the same methodology outlined for AGO2. 
MNAse Sequencing analysis 
592534546 reads were sequenced for AGO2 Knock Down 
sample. 711051028 reads were sequenced for control sample. 
Sequence quality was assessed using FastQc v 0.10.1. 
(http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) 
Paired End reads were aligned using bowtie v 0.12. 
bowtie -S -p 4 -3 10 -5 1 -n 1 -l 25 -m 1 -q --
nomaqround bowtie-0.12.7/indexes/hg19 -1 
Sample$_R1_001.fastq –Sample$_R2_001.fastq 2> 
bowtie_L006.log | samtools view -Sb -f 0x2 - > 
Sample$.bam 
samtools view -f 0x02 Sample$.bam > 
Prop.Paired.Sample$.bam 
##Length distribution computing: 
cat <(samtools view Prop.Paired.Sample$.bam) 
<(samtools view Prop.Paired.Sample$.bam | awk -
F'\t' 'function abs(x){return ((x < 0.0) ? -x : x)} 
{if (abs($9) < 162 && abs($9) > 115 ) print $0}') | 
samtools view -Sb - | bamToBed -i - | sed 
'N;s/\n/\t/' | cut -f 1,2,9 | slopBed -b 1 -g 
../human.hg19.genome -i - | awk 'NF >0 { print ($3- 
$2) }' | sort | uniq -c> length.distr.Sample$ 
• I therefore selected Paired End reads with a size 
between 100 and 200 nt.  
After such selection I obtained: 
206561235 fragments for AGO2 Knock down sample 
240239066 fragments for Control sample 
#Danpos: 
for i in {1..22..1} 
do 
out1="chr$i.1.bam" 
chr="chr$i" 
 
cat <(samtools view -H Sample$_PropPair.bam) 
<(samtools view Sample$_PropPair.bam) | fgrep -w 
"$chr" | samtools view -Sb - > 
Sample$/danpos/$out1 
python danpos-2.1.2/danpos.py 
Sample$/danpos/:Sample$i/danpos/ -o 
samples.comparing$chr -p 1 
rm Sample$/danpos/$out1 
done  
 
chrx="chrX" 
$out1 ="chrx.bam" 
cat <(samtools view -H Sample$_PropPair.bam) 
<(samtools view Sample$_PropPair.bam) | fgrep -w 
"$chrx" | samtools view -Sb - > 
Sample$/danpos/$out1 
python danpos-2.1.2/danpos.py 
Sample$/danpos/:Sample$i/danpos/ -o 
samples.comparing$chrx -p 1 
rm Sample$/danpos/$out1 
done  
 
#NucleR: 
#alignments must be split by chromosome before 
#using nucleR: 
#!/bin/bash 
 
for i in {1..22..1} 
do 
out1="chr$i.bed" 
chr="chr$i" 
 
grep -w "$chr" <(gunzip -c 
Sample$.Prop_Paired.100_200_sorted.bed.gz) | cut 
-f 1,2,3,6  > Alignments_split_by_chr/$out1 
 
done  
 
chrx="chrX" 
$out1 ="chrx.bed" 
 
grep -w "$chrX" <(gunzip -c 
Sample$.Prop_Paired.100_200_sorted.bed.gz) | cut 
-f 1,2,3,6  > Alignments_split_by_chr/$out1 
done  
 
R 
library("rtracklayer") 
chr$.sample$ <- import.bed("chr$.bed", 
asRangedData=T) 
library("nucleR") 
reads_trim = processReads(chr$.sample$, 
type="paired", fragmentLen=200, trim=40) 
cover_trim = coverage.rpm(reads_trim) 
rm(reads_trim) 
gc() 
htseq_raw = as.vector(cover_trim[[1]]) 
htseq_fft = filterFFT(htseq_raw, 
pcKeepComp=0.02) 
rm(htseq_raw) 
gc() 
 peaks = peakDetection(htseq_fft, 
threshold="25%", score= T, width=140)     
rm(htseq_fft) 
gc() 
nuc_calls = ranges(peaks[peaks$score > 
0.1,])[[1]] 
export(nuc_calls,"bed.files/sample$.nuc_calls.ch
r$.bed",format="bed") 
red_calls = reduce(nuc_calls) 
red_class = RangedData(red_calls, 
isFuzzy=width(red_calls) > 140) 
sum( red_class$isFuzzy=="TRUE") 
write.table(as.data.frame(red_class), 
"bed.files/Sample$.fuziness.chr$.bed", sep="\t", 
row.names=F, quote=F) 
detach(package:rtracklayer) 
export.wig(cover_trim,"wig.files/sample$.chr$") 
q() 
 
• Nucleosome Occupancy at the genomic loci of interest 
was computed using coverageBed with default options 
and a custom perl script to determine cumulative 
occupancy over multiple loci. Occupancy was 
normalized by the total number of sequenced 
nucleotides in each library taking into account Properly 
Paired read pairs with a length between 100 and 200. 
HeLaS3 TSS coordinates were based on RNA-seq 
analysis of mRNAs (see below). Occupancy profile at 
TSS overlapped by at least 30 swiRNAs was smoothed 
using supsmu function in R statistical environment with 
option span = 50.  Nucleosome +1 occupancy was 
defined as the sum of the coverage at each nucleotide 
position in the interval between nt +100 and nt +300 
relative to TSS. For each group of genes that were 
selected based on the minimum number of swiRNAs 
mapping within ± 150 nt of TSS. A paired t-test was 
performed to compute P-value of the difference 
observed between average coverage at nucleosome +1 
in AGO2 knock down and Ctrl siRNA cells. For each 
group of n genes (whose TSS were overlapped by at 
least m swiRNAs) 10000 random permutations were 
performed to estimate FDR. In each permutation n 
random genes were chosen (among the 21265 genes 
expressed in HeLaS3 cells) and the P-value was 
computed comparing occupancy at nucleosome +1 with 
the same procedure outlined above for the real case. All 
real cases with a P-value < 0.01 were tested, and FDR 
was always estimated to be < 0.01.   
  
 
 
 
 
 
 
 
 
 
 
DISCUSSION 
The main goal of the present thesis has been to set up an 
extensive bioinformatics analysis in order to shed light on the 
functional roles of AGO2-SWI/SNF interaction in nuclei of 
human cell lines. Indeed, we have previously demonstrated in 
our laboratory that nuclear AGO2 interacts with SWI/SNF 
complexes in nuclei of human cell lines (HCT116; HeLa S3; 
HEK293T; Jurkat cell lines) and their interaction is 
independent of DNA or RNA.  
The results here reported highlight both the bioinformatics 
pipeline, set up for the analysis of the huge amount of data 
produced from Next-Generation Sequencing experiments, as 
well as the biological relevance of the obtained outputs. 
Notably, I have identified a novel class of endogenous, AGO2-
associated and Dicer-dependent small RNAs (sRNAs) in nuclei 
of HeLa S3 cell lines. The bioinformatics recursive mapping to 
several classes of already annotated sRNAs (eg. miRNAs, 
rRNAs/tRNAs, snoRNAs), allowed me to exclude from my 
analysis any previously described class of sRNAs, searching 
for novel sRNAs. This data investigation brought to my 
attention low-copy abundance transcripts that, moreover, do 
not show the biological characteristics necessary to be 
considered putative microRNAs, as highlighted by the output 
of my analysis with miRanalyzer. 
Previous reports (Euskirchen et al., 2011) have characterized a 
genome-wide map of SWI/SNF binding sites in HeLa S3 cell 
lines. The use of bioinformatics tools allowed me to intersect 
these publicly released data sets (ENCODE ChIP-seq data) and 
the genomic coordinates of the filtered sRNAs present in my 
data sets. Such analyses allowed me to figure out that this 
novel class of AGO2-bound sRNAs arise from SWI/SNF-
bound TSS, therefore here referred at as “swiRNAs”.  
Moreover, the Dicer processing I have demonstrated, allows to 
hypothesize  that complementary long TSSa RNA pairs (Valen 
et al., 2011; Seila et al., 2008) might be swiRNAs precursors.  
Several experimental evidence indicates that AGO proteins in 
association with sRNAs can regulate nuclear processes in yeast 
and plants (Grewal et al., 2007; Matzke et al., 2009), 
suggesting that RNAi might similarly operate in animals. Our 
identification of a new macromolecular complex including 
AGO2, core components of SWI/SNF and swiRNAs suggests 
the involvement of AGO2 in novel and uncharacterized 
functions in mammals. It has been recently shown that genetic 
ablation of key subunits of SWI/SNF specifically affects 
nucleosome occupancy at TSS (Tolstorukov et al.,2013), 
suggesting that SWI/SNF function is of great importance for 
the proper positioning of nucleosomes around TSS. My data 
highlight that AGO2 depletion in HeLa S3 cells affects 
nucleosome occupancy as well. Importantly the canonical tools 
used to compute nucleosome occupancy changes, such as 
Danpos and NucleR, failed to identify differences between 
AGO2 knock down cell lines and control. This is because these 
algorithms perform statistical tests on each single nucleosome 
present all over the genome. On the contrary, my 
bioinformatics pipeline focused only on a subclass of 
nucleosomes: the ones around TSS. Thus, computing the 
average nucleosome occupancy profiles around all TSS, I 
managed to highlight actual differences upon AGO2 knock 
down. In order to get very precise results, I used the TSS 
coordinates of the 21.265 genes expressed in HeLaS3 derived 
on my previous RNA-seq analysis of mRNAs under the same 
growth conditions. Interestingly, the overall nucleosome 
occupancy changes, even if statistically significant, were not 
much appreciable when considering all TSS coordinates. On 
the contrary, by restricting my analysis only on TSS bound by 
swiRNAs and I observed an important reduction of nucleosome 
+1 occupancy. Finally, the more swiRNAs map around the 
considered TSS, the bigger was the change in nucleosome +1 
occupancy in AGO2 knock- down HeLaS3 cells. Our data also 
highlight that larger numbers of AGO1 or IgG associated 
sRNAs mapping on TSS did not correspond to stronger 
reduction of nucleosome +1 occupancy, suggesting that this 
effect is mediated by swiRNAs and not by other sRNAs.  
Taken together, these data have brought to the formulation of 
the biological model presented in FIG. D1. We propose that 
swiRNAs mediate recruitment of nuclear AGO2  and SWI/SNF 
onto targeted TSS to ensure proper nucleosome +1 positioning. 
Further experiments with AGO2 knock-out cell lines will be 
necessary in order to elucidate whether the small, although 
statistically highly significant, occupancy reduction observed 
in AGO2 knock-down may be due to the fact that residual 
AGO2 protein in AGO2 knock-down cells may still recruit, 
although to a lesser extent, SWI/SNF onto targeted TSS. 
 mRNA expression profile analysis, which on the contrary does 
not reveal any significant change in gene expression upon 
Ago2 knock-down, needs to be more deeply investigated. 
Indeed, the nucleosome +1 differential positioning in AGO2 
knock-down cells could alter in the canonical splice patterns 
(Ameyar-Zazoua M. et al., 2012). Moreover, an alternative TSS 
usage for the same gene needs to be investigated as well. 
  
 
 
 
 
 
 
 
 
Fig D1: A schematic model depicting the role of AGO2-SWI/SNF-
swiRNA complex in chromatin remodelling in mammalian cells. 
Divergent transcription at active promoters gives rise to sense (blue) and 
antisense (red) TSSa RNAs. Complementary TSSa RNAs might form 
dsRNA, which are subsequently processed by DICER to produce swiRNAs. 
In the nucleus AGO2 loaded with swiRNAs recruits SWI/SNF complex on 
target TSSs through complementarity between swiRNA and nascent 
promoter transcripts. The AGO2-swiRNA-SWI/SNF complex maintains the 
typical nucleosome occupancy signature at TSS, which is characterized by a 
nucleosome free region spanning the TSS, flanked by two well-positioned 
nucleosome (+1 and –1 nucleosome; dark red). Following depletion of 
AGO2, the occupancy of nucleosome +1 decreases (light red).  
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